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Fluid diodes are fluidic devices that enhance fluid flow in a particular direction
while inhibiting it in the opposite direction without the use of moving parts. This
is accomplished through the use of nozzle shaped geometry on one side of the diode,
and cusp shaped geometry on the opposing side. Fluid meets very little resistance
as is travels though the nozzle side of the diode. The cusps on the other side of the
diode reduce the effective flow area, thereby inhibiting flow. The objective of this
study is to determine the effectiveness of a fluid diode installed in a reconstructed
cardiovascular system of an infant diagnosed with hypoplastic left heart syndrome.
The fluid diode is not used inside the heart, but rather inside a shunt connecting
the ventricle to the pulmonary artery. Currently, patients are experiencing regurgitant blood flow inside this shunt, which is known as a Sano shunt. This regurgitant
volume increases the workload of the ventricle, which can lead to myocardial hypertrophy and eventual cardiac failure [1, 2]. The principle objective of this thesis is to
characterize the performance of certain diodes by testing them experimentally using
a mock circulatory system.
Experiments were performed on three different size diodes-in-shunts as well as
three different size empty shunts. The data from each diode-in-shunt test was compared to the data from each empty shunt test in order to determine if any performance

gain was present. The regurgitant fraction (RF%) as well as the individual systolic
and diastolic flow volumes were used to evaluate the performance of both the diodesin-shunts as well as the empty shunts.
The earlier experiments were conducted with the diode situated in the middle of
the shunt. By moving the diode to the entrance of the shunt, the RF% was improved
by as much as 51%. However, with only three different size diodes-in-shunts as well as
three different size empty shunts available for testing, it is hard to draw any definitive
conclusions as to whether or not a diode can maintain the same systolic flow levels
while reducing diastolic flow levels. Further testing using different diameter diodes is
required.
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Chapter 1
Introduction
Every year in the United States, approximately 1,000 infants are born with a
disease known as hypoplastic left heart syndrome (HLHS) [3]. This congenital heart
defect stunts the growth of many of the components of the left side of the heart. In
order to survive, the infant must undergo a series of three palliative procedures, the
first of which is known as the Sano-Norwood procedure. The end result of this procedure is such that the right ventricle must now pump blood to both the pulmonic and
systemic circulations without the assistance of the left ventricle. Systemic circulation
is accomplished though the use of a newly constructed aorta, which is connected directly to the right ventricle. The former pulmonary valve now sits at the entrance
of the aorta, preventing regurgitation. Pulmonic circulation is accomplished through
the use of a small shunt, only 5mm in diameter, known as the Sano shunt. This Sano
shunt is a simple tube made of GORE-TEX connecting the right ventricle to the
pulmonary artery [4]. However, there is no valve installed to prevent regurgitation.
Although studies have shown that infants undergoing the Sano-Norwood procedure
have approximately a 75% - 80% survival rate, the leading cause of death is heart
failure due to the excessive workload placed on the right ventricle as a result of the
extra volume of regurgitant blood that it must pump [5, 6].
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In order to resolve the issue of regurgitation, a valve could be installed inside the
Sano shunt. The two main types of heart valves in use today are mechanical and bioprosthetic valves. A disadvantage of mechanical valves is the associated necessity of a
prescribed anticoagulant. Anticoagulants can lead to complications during additional
surgeries, which are frequently required after the Sano-Norwood procedure [6,7]. The
disadvantage of bioprosthetic valves is their susceptibility to degeneration, which only
increases in pre-adult patients [8, 9].
The purpose of this study is to determine whether an alternative type of valve,
known as a fluid diode, can maintain the current systolic blood flow levels observed
in Sano shunts while improving upon the regurgitation experienced during diastole.
A diode in the traditional sense is an electronic component that permits current flow
in one direction and resists current flow from the opposing direction. A fluid diode
is used for a similar purpose. However, instead of using doping technology to dictate
the electrical current flow, a fluid diode’s own geometry is designed to enhance fluid
flow in one direction, while resisting fluid flow in the opposite direction. One side
of the fluid diode is made to function as a nozzle, thereby increasing antegrade flow.
The opposite side of the fluid diode is machined with cusp shaped geometry, which
restricts the effective flow area, thereby impeding retrograde flow.
The diodes used in this study were originally designed by several UNL undergraduate students who used steady state CFD simulations to optimize the geometry
of each diode. They then tested the diodes experimentally, using water columns to
create a fixed pressure across the test section where the diode was installed [10]. In
the present study, the performance of the fluid diode in pulsatile flow is studied experimentally through the use of a mock circulatory system. Experiments were first
completed using empty rigid Sano shunts. Physiological pressure gradients derived
from in vivo experiments were generated across the shunts, and the resulting flowrate
data and level of regurgitant flow was recorded. Using a similar pressure waveform,
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the same experiments were completed with a diode installed inside the Sano shunt.

Chapter 2
Background
The human heart consists of four individual chambers that function as two separate pumping systems working in tandem to circulate blood throughout the body.
The right side or low-pressure side of the heart receives de-oxygenated blood from the
systemic circulation, and delivers it to the lungs, where oxygen molecules from the
lungs are bound to iron molecules present in hemoglobin, the main protein present in
red blood cells. The left side or high-pressure side of the heart delivers oxygenated
blood to the rest of the body via the systemic circulation.

2.1 Cardiovascular Physiology
As shown in Figure 2.1, each side of the heart consists of one atrium chamber and
one ventricle chamber. The two upper chambers, the atria, receive blood returning
to the heart and deliver it to the two lower chambers of the heart, the ventricles,
which then pump blood to the rest of the circulatory system. There are a total of
four valves inside the human heart; two atrioventricular valves that direct blood flow
from the atria into the ventricles, and two semilunar valves, one at the entrance to
each major artery leaving the heart. The right atrioventricular valve is known as
the tricuspid valve, whereas the opposing left atrioventricular valve is referred to as
4
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Figure 2.1: Normal Cardiac Cycle [11]
the mitral valve. The right semilunar valve is simply known as the pulmonary valve,
whereas the left semilunar valve is known as the aortic valve.
The cardiac cycle consists of two discrete phases, systole and diastole, both of
which are described via the illustration in Figure 2.1. During diastole, or the period
of the cardiac cycle when the myocardium (heart muscle) is not contracting, deoxygenated blood from the systemic circulation enters the right atrium (RA) via
the two largest veins in the circulatory system, the inferior and superior vena cava
(IVC and SVC). At the same time, oxygenated blood from the lungs enters the left
atrium (LA) via the pulmonary veins. Blood continues to flow from the atria via the
atrioventricular valves and into the ventricles (LV and RV). At the end of diastole,
both atria contract, thereby forcing even more blood into the ventricles.
During systole, both ventricles contract, forcing both of the atrioventricular valves
shut. De-oxygenated blood is forced out of the right ventricle (RV) through the
pulmonary valve and then into the lungs, via the pulmonary arteries (PA). At the
same time, blood is forced out of the contracting left ventricle into the aorta (Ao),
and on to the rest of the systemic circulation.
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2.2 Hypoplastic Left Heart Syndrome
Hypoplastic left heart syndrome is a congenital heart defect that effects nearly
1,000 infants each year in the United States [3]. During pregnancy, the left side of the
heart of children afflicted with this disease does not develop properly. When the child
is born, a majority of the structures on the left side of their heart are either absent or
severely underdeveloped. The mitral and aortic valves are typically extremely small
or completely occluded. The left ventricle and ascending aorta are also usually very
undersized. This inhibits the heart’s ability to effectively pump oxygen-rich blood to
the rest of the body. Children born with HLHS can survive after birth because for a
short while, their heart can bypass the left ventricle. Oxygenated blood flowing from
the lungs can pass through the left atrium and into the right atrium through the atrial
septal defect, which is a defect or hole in the interatrial septum that separates the left
and right atria. This defect is commonly seen in children with HLHS. Oxygenated
blood is carried to the body through a small blood vessel connecting the pulmonary
artery to the descending aorta. This blood vessel, known as the ductus arteriosus
naturally closes several days after birth. Using medication, this vital blood vessel can
be kept open until surgery can be performed. A depiction of the pathologic anatomy
present in patients with HLHS can be seen in Figure 2.2 (a).

2.3 Palliative Procedures for HLHS
The most common treatment method is a series of three or more palliative procedures designed to separate the systemic and pulmonary circulations thereby enabling
passive blood flow into the pulmonary arteries while the functional right ventricle
pumps blood to the systemic circulation. Until recently the preferred first stage
operation was the Norwood procedure [12]. This procedure is typically performed
within a few days of birth. The Norwood procedure, first successfully performed by
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(a)

(b)

Figure 2.2: (a) Pathologic Anatomy of HLHS. (b) Norwood Procedure. [15, 16]
Dr. William Norwood in 1981, serves to provide the right ventricle with the means
to supply blood to both the systemic and pulmonary circulatory systems [13]. The
steps of this procedure are detailed in Figure 2.2 (b).
The first step involves the enlargement of the ascending aorta. This is done by
first severing the pulmonary artery above the pulmonary valve, and then using part
of that tissue as a graft to enlarge the underdeveloped aorta. Usually, another piece
of homograft or donor tissue is required to complete the construction of this new or
“neoaorta”. Pulmonary circulation is then reestablished through the use of a small
shunt, several millimeters in diameter, referred to as the modified Blalock-Taussig
shunt (MBT), which connects the innominate artery, which is an artery that stems
from the arch of the aorta, to the right pulmonary artery. Finally, the atrial septal
defect is permanently widened to permit oxygenated blood flow between the two
atria [14].
After the procedure is concluded, a mixture of oxygenated and deoxygenated
blood will flow though both the systemic and pulmonary circulatory systems. Studies
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have shown that the arterial oxygen saturation level of this mixture is approximately
75% [17, 18]. Although these levels are high enough to ensure proper organ function
and prevent hypoxemia, which is a condition categorized by unusually low oxygen
levels in the arterial bloodstream, they are still well below the normal levels of arterial
oxygen saturation [19]. Ideally, arterial oxygen saturation levels should be above
95% [19]. Studies have also shown that HLHS patients with low postoperative oxygen
saturation levels score “significantly below the population mean for motor, visualmotor integration, and composite neurodevelopmental outcomes” [17].
Another issue facing post operative Norwood patients is the volume overloading of
the right ventricle. Because the right ventricle must now supply blood to the systemic
circulation in addition to the pulmonary circulation, the ventricle becomes volume
overloaded. This volume overload translates to increased wall stress via Laplace’s
Law, which in turn triggers myocardial hypertrophy, which is a physiologic adaptation
that stimulates the growth of the myocardium [1]. Although the hypertrophied heart
may function under this abnormally heavy workload for years, this condition would
eventually lead to heart failure [2].
In order to correct the issues of volume overload and low oxygen saturation, two
more procedures known as the Glenn and Fontan procedures, are required. The Glenn
procedure is typically performed within 4 - 6 months of birth. The procedure involves
severing the superior vena cava from the right atrium and reattaching it directly to
the pulmonary artery. Because the superior vena cava can deliver more blood than
the smaller diameter MBT shunt ever could, the MBT shunt is no longer required,
therefore it is removed [14, 20].
The Fontan procedure is usually performed when the child is between 1 1/2 4 years of age. During this final procedure, the inferior vena cava is severed just
below the right atrium, and then reattached to the pulmonary artery. After these
two operations are complete, the child’s oxygen levels should return to normal, and
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the extra workload on the right ventricle should be removed. These procedures are
not performed immediately after birth because the pulmonary vascular resistance in
newborns is too high [21].
The procedure that is of interest in this study however, is a modification of the
Norwood procedure, known as the Sano-Norwood procedure. The goal of this procedure is to address the issue of coronary steal due to the diastolic runoff present in the
modified Blalock-Taussig shunt [4, 15]. The act of supplying blood to an organ’s capillaries is known as perfusion, and approximately 70-80% of coronary perfusion (blood
flow to the heart muscles) occurs during diastole [22]. Continuous forward blood flow
through the MBT shunt occurs during both systole and diastole [22]. Therefore, it has
been postulated the coronary arteries in patients who have undergone the Norwood
procedure do not receive the proper amount of blood because it has been “stolen” by
the MBT shunt. This problem is referred to as coronary steal. Although it is difficult
to determine the exact cause of death in many post Norwood operation cases, it has
been postulated that coronary insufficiency plays a large role [15, 22].
During the Sano modification of the Norwood procedure, the construction of the
neo-aorta as well as the widening of the atrial septal defect are performed in the exact
same manner as they were in the Norwood procedure [23]. However, pulmonary circulation is instead permitted via a shunt reconnecting the branches of the pulmonary
artery directly to the right ventricle [23]. Because this “Sano shunt” is connected
directly to the right ventricle, the possibility for coronary steal is eliminated [15, 22].
However, the Sano modification does have a distinct disadvantage in comparison
to the standard Norwood procedure. Because no valve separates the blood flowing
through the shunt and the right ventricle as the pulmonary valve did in the Norwood procedure, blood flow regurgitates into the right ventricle during diastole. This
additional regurgitant blood flow into the right ventricle contributes to the volume
overload already present, thereby exacerbating the effects of myocardial hypertrophy.
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A possible solution to this problem would be the implementation of a valve inside
the Sano shunt to prevent regurgitant flow during diastole. There are several possible
categories of prosthetic valves that could be considered for this particular application.
The first option would be some type of mechanical valve such as a tilting disc or
bileaflet valve. One disadvantage of even the most reliable mechanical valve is the
fact that the moving parts induce areas of high shear stress and turbulence [7]. This
can damage passing red blood cells or result in platelet activation, which causes
platelets to adhere to one another, which can lead to blood clotting [7, 24]. Due
to this risk, patients with mechanical valves must take some form of anticoagulant
medication. Anticoagulants can complicate matters when the patient is undergoing
emergency surgical procedures [23]. A 2013 study found that nearly 43% of sampled
patients who underwent the either the Norwood or Sano-Norwood procedure required
an additional emergency intervention procedure [6].
Another possibility would be the use of a bioprosthetic replacement valve. Bioprosthetic valves are created from the tissue of an animal donor’s valve. The advantage
that bioprosthetic valves have over mechanical valves is their ability to closely mimic
physiological blood flow without inducing high levels of shear stress or turbulence [25].
The disadvantage of bioprosthetic valves is their susceptibility to degeneration as they
calcify and wear. This is especially prevalent in bioprosthetic replacements in children
due to their increased calcium metabolism rates [23].

2.4 The Fluid Diode
An alternative option to either the mechanical or biological valves is an engineering device known as a fluid diode. A mechanism with no moving parts, the fluid
diode resists retrograde flow more so than it resists antegrade flow through the use
of carefully designed geometry. An example of one of the fluid diodes used in this
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(a)

(b)

Figure 2.3: UNL Fluid Diode: (a) Isometric View. (b) Cross-Sectional View.
study, referred to as the UNL diode, may be seen in Figure 2.3. One side of the UNL
diode is designed to function as a nozzle, thereby increasing antegrade flow. The opposing side of the UNL diode functions as a sort of fluidic valve. The boundary layer
flow is unable to accelerate quickly enough in order to follow the sudden change in
geometry that occurs at the cusp edge. This inability of the flow to follow the curve
of the diode results in significant flow separation. In theory, this should result in
a vena contracta, thereby reducing the effective area through which the regurgitant
flow can pass through. This effect is illustrated in the flow profiles shown in Figure 2.4 [26]. This flow separation should extract considerable energy from the main
stream, thereby leading to a significant pressure loss.
An early example of a fluid diode can be seen in Nicola Tesla’s Valvular Conduit,
patented in 1920, which is depicted in Figure 2.5. This device was developed to
replace series of conduits and valves inside machinery such as reciprocating pumps,
compressors, and gas turbines. A fluid under pressure entering the conduit from the
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Figure 2.4: Basic Systolic (Left) and Diastolic (Right) Flow Profiles Through Fluid
Diode [9]
right at position 5 in Figure 2.5 would encounter little resistance other than viscous
resistance as it moves from right to left. However, fluid entering from the left at
position 4 would quickly be directed around a partition (No. 3) and into what Tesla
refers to as buckets (No. 2), which are designed to create eddies to interfere with
the fluid flowing along the centerline. Although the overall geometry of Tesla’s diode
differs substantially from the diode used in the present study, the principles laid forth
by Tesla are implemented in the construction of the diode [27].

Figure 2.5: Tesla’s Valvular Conduit [27]
The fluid diode that served as the inspiration for the UNL diode was designed in
2004 as prosthetic pulmonary valve by a graduate student at Clemson University [28].
This diode was used in three separate studies at Clemson [7, 26, 28]. However, no
other studies utilizing fluid diodes for any biological applications were ever discovered.
The initial study compared the performance of a human heart with the Clemson
diode installed in the pulmonary valve position to that of a human heart with a
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missing pulmonary valve [28]. During this study, the Clemson diode exhibited a 25%
improvement of the reverse to forward flow ratio (otherwise known as the regurgitant
fraction or RF%) when compared to the missing valve case. The RF% achieved
using this diode was 15.8 ± 0.1% for a cardiac output of 5.8 Lpm. These results
supported the hypothesis that a fluid diode could be used as a replacement pulmonary
valve [28]. The next Clemson diode study was performed in 2009. Again, the diode
was to be used as a replacement pulmonary valve. The performance of a 25mm
OD/12.5mm ID diode was gauged using blood analogue in a mock circulatory system.
A hydraulic resistance designed to mimic the resistance of the pulmonary vascular
bed was created inside the mock circulatory system. This resistance is known as
the pulmonary vascular resistance, or PVR. At a frequency of 75bpm, and a cardiac
output of 5Lpm, the diode was tested at PVR values ranging from 1 – 5 mmHg/Lpm.
With the PVR set to 0.9mmHg/Lpm, the diode exhibited a RF% of 2%. At a PVR
of 4.5mmHg/Lpm, the diode exhibited a RF% of 17%. During this 2009 study, PIV
technology was utilized to determine whether the shear stresses in the flow through the
diode would be high enough to induce platelet activation. The PIV results indicated
that during experiments where the diode exhibited a RF% less than 20%, the shear
stresses and turbulence were not high enough to activate platelets [7]. The final
study performed in 2011, built upon the previous experiments by determining to
what extent a replacement diode pulmonary valve could reduce the workload on the
right ventricle. 2-D visualization studies were performed in a mock circulatory system
using PIV technology to visualize flow profiles within the diode. The results of those
flow visualization studies can be seen in Figure 2.6. By measuring the width of the
vena contracta, it was determined that the Clemson diode reduced the effective flow
area by 48% [26].
Although the diameter of the Clemson diode was several times larger than that of
the UNL diode, the ratio of inner to outer diameters otherwise known as the beta ratio
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(a)

(b)

Figure 2.6: Flow Visualization During Systole (a) and Diastole (b) [9]
is equivalent in both diode designs. Culbreath (2004) demonstrated through steady
flow simulations that the highest ratio of reverse flow pressure drop to forward flow
pressure drop occurs at a beta ratio of 0.5 [29]. The nozzle of both diodes is shaped
exactly like a single quadrant of an ellipse. As shown through flow visualization
studies performed on the Clemson diode, this nozzle geometry directs flow forward
through the diode creating a strong jet without creating a vena contracta effect.
[14]. The geometry of the UNL diode was based off the results of a large number of
fully developed, steady state flow CFD simulations designed to optimize the ratio of
forward to reverse flow by adjusting several key geometrical parameters [10]. These
parameters, depicted in the schematic of the UNL diode in Figure 2.7, are the outer
and inner diameters of the diode as well as the depth of the cusp and the cusp angle.
The UNL diodes were all manufactured from Delrin, a crystalline plastic known for
its excellent machinability [30]. Three fluid diodes of each of the following outer diameters were machined: 5.93mm, 7.07mm, 9.69mm, 11.09mm, and 12.07mm. However,
in the present study, only the 7.07mm, 9.69mm, and 11.09mm diodes were evaluated.
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Figure 2.7: UNL Diode Schematic [9]

2.5 Pulsatile Flow
Pulsatile flow is defined as flow with a periodic pressure fluctuation wave traveling
along the flow path. Similar to Poiseuille flow, the pressure difference between two
points is used to determine the instantaneous flowrate. However, in pulsatile flow,
both the pressure difference and flowrate vary periodically with time [31]. Therefore,
one would expect a complex relationship between pressure and flowrate. However, an
analytical solution of the Navier-Stokes equation can be derived for an incompressible,
laminar, pulsatile, fully developed, axisymmetric flow of a Newtonian fluid. One
particular solution, known as the Womersley solution, is comprised of both a steadystate Poiseuille term as well as an oscillatory term that generates zero net flow. The
Womersley solution can be seen in equation 2.1 [32].
 p o R2
ps 2
r − R2 +
u(r, t) =
4µ
iµα2

(

)
J0 Rr αi3/2
1−
eift
J0 (αi3/2 )

(2.1)

In the Womersley solution, ps is is the steady-state pressure gradient, i is the
imaginary unit, f is the frequency of the pressure pulsations, t is the time, r is the
radial coordinate, po eift is the oscillatory pressure gradient, µ is the dynamic viscosity
of the fluid, R is the vessel radius, and J0 is a Bessel function of order zero and
first kind. The first term on the right hand side of equation 2.1 is the standard
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Poiseuille solution, while the second component is the flatter, oscillating velocity
profile representing the transient inertia effects [32]. α represents the dimensionless
parameter known as the Womersley number. When characterizing the effects between
inertial forces and viscous forces in pulsatile flow, either the Womersley number or a
combination of the Reynolds (Re) and Strouhal (St) numbers are used [33].
r
Womersley Number : α = R

Reynolds Number : Re =

Strouhal Number : St =

2πf
ν

(2.2)

2uR
ν

(2.3)

fL
u

(2.4)

In the above equations, R represents the pipe radius, f represents the frequency of
pulsations, ν represents the kinematic viscosity of the fluid, u represents the velocity
of the fluid, and L represents the characteristic length of the pipe. The Womersley
number defines the ratio between transient inertial forces and viscous shear forces.
The Reynolds number describes the ratio between inertial and viscous forces, whereas
the Strouhal number describes the ratio between local inertial forces and convective
inertial forces. The Womersley number can be written in terms of the Reynolds and
Strouhal numbers in the following manner: [34, 35]

α = (2πReSt)1/2

(2.5)

In pulsatile flows, a small Womersley number (α < 1) suggests that viscous forces
dominate, and the frequency of the system is low enough that a parabolic velocity
profile can develop during each cycle. During tests completed at low Womersley numbers, the time-flowrate waveform should be in phase with the time-pressure difference
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waveform. The relationship between pressure and flow should also be approximately
equivalent to that of the Poiseuille solution. A large Womersley number (i.e. > 10) indicates that inertial effects dominate viscous effects. In these flows, the time-averaged
velocity profile is flat and the flowrate waveform will lag behind the pressure difference
waveform by approximately 90°. At higher Womersley number flows, the flowrate is
just a fraction of what the Poiseuille flow would be if operating under the same pressure difference. Womersley illustrated the effects of his dimensionless parameter in his
1954 paper on the study of hemodynamics in arteries through the use of the diagram
shown in Figure 2.8. [36]

Figure 2.8: The Effect of the Womersley Number on: (A) The Ratio of the Maximum Flowrate Due to an Oscillating Pressure to the Corresponding Steady, Poiseuille
Flowrate; and (B) The Phase Lag Between the Oscillating Pressure and Flow [36]
In standard Poiseuille flow, the transition from laminar to turbulent flow is well
documented. Flows with Re < 2000 are known to be laminar, flows with Re > 4000
are know to be turbulent, and flows with 2000 < Re < 4000 are assumed to be in a
transition between laminar and turbulent flow [37]. The velocity profiles are usually
indicative of flow regime as well. A parabolic velocity profile is usually representative
of laminar flow, whereas a flat time-averaged velocity profile is typically representative
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of turbulent flow. Unfortunately, the transition from laminar to turbulence in pulsatile
flow is not as clearly defined. Even many of the experimental studies conducted on the
transition from laminar to turbulence in pulsatile flows contradict one another [32].
In order to use the Womersley solution, not only must the flow regime be determined, the other aforementioned assumptions must also be met. In regards to the
other requirements, firstly, it is safe to assume that blood, like water, is an incompressible fluid [25]. Next, is blood a Newtonian fluid? The heterogeneous nature of
blood might indicate that blood cannot even be treated as a continuum. However,
studies have shown that when the vessel diameter through which the blood is travelling is large compared to the scale of the elements present in blood such as blood
cells, plasma, and platelets, the assumptions that blood is Newtonian as well as a
continuum, have proved to be accurate [9]. Through the use of empirical data, it
has been proven that the threshold vessel diameter size for Newtonian behavior is
approximately 200µm [38].
As stated previously, the pulsating nature of blood blurs the distinction between
laminar and turbulent flow regimes. Although it is universally agreed that the vast
majority of flow in the circulatory system is laminar, the two instances where most
studies have indicated that turbulent flow is most likely to occur is in in the ascending
aorta and in stenosed arteries [39–41]. Although the Sano shunt is not part of the
aorta, it does receive blood flow directly from the same ventricle that the aorta does.
Also, flow through a diode inside a Sano shunt could possibly behave similar to
flow through a constricted artery. Although researchers agree that turbulent flow
could possibly exist in these scenarios, much of the experimental studies detailing
when the transition takes place and by what mechanisms have produced conflicting
results [32, 39]. Several experimental studies were analyzed in order to determine
what flow regime may be present inside the flow through the diode-in-shunt.
Trip and Kuik et al performed an experimental study of transitional pulsatile
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pipe flow. The dimensionless parameters used to characterize the sinusoidal pulsating
blood flow in this study are the mean Reynolds number, Rem , the oscillatory Reynolds
number, Reo , and the Womersley number, α. [32]

Mean Reynolds Number : Rem =

2us R
ν

Oscillatory Reynolds Number : Reo =

r
Womersley Number : α = R

2uo R
ν

2πf
ν

(2.6)

(2.7)

(2.8)

Here, u defines the axial velocity component, which is comprised of steady and
oscillating components, us and uo , respectively. These three dimensionless parameters
are used in an attempt to determine when the transition to turbulent flow occurs in
pulsatile flow. [32]
In this particular study, researchers designed an in vitro arrangement to create
pulsatile flow through a long, smooth pipe with an inner diameter of 40mm. An orifice
plate with a diameter of 30mm, which is used to transition flow to turbulence, was
placed just upstream of the entrance to the pipe. The entrance length for laminar,
oscillating pipe flow was estimated using the relationship: L/D = 0.049Rem . The
entrance length for turbulent flow is even smaller than the entrance length for laminar
flow. Particle image velocimetry was used to measure velocity components, or more
specifically, the non-periodic, or turbulent fluctuations of the velocity components.
The turbulent fluctuations of the velocity along with the bulk velocity were then used
to calculate the turbulence intensity, I. To determine the critical Reynolds number,
turbulence intensity was plotted as a function of normalized time as depicted in Figure
2.9. Sudden lone increases in turbulent intensity, which are quickly damped by low
velocity diastolic flow, indicate laminar flow. Once the critical Reynolds number is
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reached however, the turbulence intensity of the flow remains at an elevated state,
indicating turbulent flow. In this particular series of tests, this occurs somewhere in
between a Rem value of 2527 and 2761. In general, Trip et al. discovered that the
transition region occurs somewhere in the region of Rem = 2250 - 3000. [32]

Figure 2.9: Turbulence Intensity, I as a Function of Normalized Time for Four Different Rem . Reo = 610; α = 25 [9]
In order to determine the effect that Rem and α have on turbulence intensity,
the turbulence intensity is normalized by the centerline velocity and plotted as a
function of Rem . This plot can be seen in Figure 2.10. The tests were completed
at several different frequencies; therefore the effects of the Womersley number can
be seen as well. As was shown in Figure 2.9, the critical mean Reynolds number
occurs somewhere between 2527 and 2761. An interesting observation that can be
made upon examining Figure 2.10 is the apparent lack of effect that the Womersley
number has on turbulence intensity. The authors state that the effect pulsation has
on the transition to turbulence is limited to Womersley numbers smaller than 10.
This finding agrees with a 1986 study performed by Stetller and Hussain on pulsatile
flow. They found that as α increases, the critical Reynolds number first increases
quickly, reaches a maximum at α = 5, then decreases to an asymptotic value near
α = 10 [42].
Nerem and Seed performed an in vivo study of aortic flow disturbances. They
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Figure 2.10: Turbulence Intensity Normalized by the Centerline Velocity as a Function
of Rem . [9]
studied pulsatile flow though canine aortas by measuring the velocity of blood flow
using a hot film needle probe. As in the previous example study, the presence of
turbulence is noted in random fluctuations in velocity. The velocity fluctuations that
indicate turbulent flow are of high frequency and small amplitude, typically only
about 10% of the amplitude of mean velocity. Only two dimensionless parameters
c and the Womersley number.
were used in this study; the peak Reynolds number, Re
c differs from Rem and Reo in that the peak pulsatile velocity component is used
Re
in place of either the steady state or oscillatory velocity component. Nerem and
Seed postulate that even if the critical peak Reynolds number is reached, if there
is not sufficient time during which disturbances can be amplified, the transition to
turbulence will not occur. [39]
Measurements were taken on six individual canines in different aortic locations,
c α,
under a variety of different cardiac conditions, providing results at various Re,
and flow states. Velocity waveforms with negligible high frequency components were
categorized as undisturbed and therefore indicative of laminar flow. Velocity waveforms with high frequency components present only during peak systolic flow were
categorized as disturbed and thought to represent transitional flow. Velocity waveforms with high frequency components that remained throughout the deceleration
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phase of systole were deemed highly disturbed and therefore characteristic of turbulent flow. The effect that both the peak Reynolds number as well as the Womersley
number have on transitional flow can be illustrated by plotting the two dimensionless
parameters against one another as shown in Figure 2.11. [39]

Figure 2.11: Peak Reynolds Number vs. Womersley Number for the Descending
Aorta. [9]
The unshaded points in Figure 2.11 represent laminar flow, whereas the half
shaded points represent transitional flow, and the fully shaded points represent turbulent flow. The lines connecting certain points indicate that they were taken from
the same canine. The general trend of the data seems to indicate that any increase
c and/or any decrease in α results in a more disturbed flow. The line separating
in Re
the undisturbed data from the disturbed data appears to follow the equation:

c crit = 250α
Peak Critical Reynolds Number : Re

(2.9)

As is shown in the above equation and in Figure 2.11, the transition from laminar
to turbulent flow can come about through a change in the Womersley number alone.
As they proved this for several Womersley numbers greater than 10, their findings are
contradictory to the findings of Trip and Kuik et al, who stated that the Womersley
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number does not influence the critical Reynolds number when α > 10. Also, many
of the flows studied by Nerem and Seed were still in the transitional phase at peak
Reynolds numbers much greater those present in turbulent flows from the study
performed by Trip and Kuik. However, Trip and Kuik’s findings do appear to agree
with Womersley’s original idea that when α > 10, it has much less of an effect on
phase lag and flowrate. [39]
As has been shown through the aforementioned studies, there is no accepted general consensus as to how dimensionless parameters should be used to determine theoretically whether pulsatile flow is laminar or turbulent. Unfortunately, the methods
used to detect the presence of turbulence experimentally in these studies are not
practical in the present study. Therefore, even though the Reynolds number as well
as the Womersley number can be accurately calculated, it is difficult to say whether
flow through the shunts and diodes-in-shunts is laminar or turbulent.
The final assumption in regards to the Womersley solution is that the flow must
be fully developed. This unfortunately cannot be satisfied either. The Sano shunts
used at the University of Nebraska Medical Center currently are only 30mm in length
and 5mm in diameter. The entrance length requirement for laminar pulsatile flow is
L/D = 0.049Rem . Even if the flow was turbulent, the entrance length requirement
is much too large [32]. Because the flow is not fully developed and the flow regime
cannot be verified, an analytical solution for flow through the Sano shunt cannot be
determined. However, the dimensionless Womersley parameter will be calculated for
each experiment, and the phase lag between pressure and flow will be analyzed as
well.

Chapter 3
Methodology
The principle objective of the present study is to test the hypothesis that a fluid
diode can improve upon the regurgitation levels present in Sano shunts while maintaining the current systolic flow levels. This will be accomplished experimentally,
through the use of a mock circulatory system, which will be used to create pressure
waveforms comparable to physiological pressure waveforms derived from in vivo data.
Blood flow in the Sano shunt is now the lone source of pulmonary blood flow, and it is
governed by the pressure drop across the shunt. The relationship between the pressure
drop and the volumetric flow per cycle will be used to characterize the performance
of the diodes-in-shunts. The pressure/flow relationships of the diodes-in-shunts will
be compared to those of rigid Sano shunts with equivalent inner diameters. Using
pressure and flowrate data acquired from the experiments performed using the mock
circulatory system, performance parameters such as the regurgitant fraction will be
calculated. These performance parameters will be used as a comparison between Sano
shunt and diode-in-shunt performance.
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3.1 Mock Circulatory System
The mock circulatory system used in this study is a Vivitro Pulse Duplicator
System. It is designed to simulate the function of the human heart by producing
physiological cardiac conditions in order to assess the performance of synthetic heart
valves. The system is composed of a model heart, a positive displacement fluid pump,
pressure and flow instrumentation, and computer hardware and software for data
acquisition and analysis. The model heart, which can be seen in Figure 3.1, along
with the Superpump, is designed to mimic either the right or the left side of the
human heart. It consists of a single atrium chamber, a single aortic chamber (which
also doubles as the pulmonary artery), an aortic root (the chamber that holds the
synthetic valves), two compliance chambers, a device designed to create peripheral
resistance, and a single ventricle chamber containing a silicone membrane. [43]

Figure 3.1: Pulse Duplicator System: Model Heart Components and Superpump [43]
The pump itself consists of a piston-in-cylinder pump head and an electric motor.
The motor is driven by a power amplifier, which uses voltage waveform signals in
tandem with position and velocity transducers to control the piston’s stroke position
and velocity. The custom voltage waveforms can be designed using the accompanying
Vivitest software. [43]
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The Pulse Duplicator System contains two separate fluid zones, which are distinguished from one another in the diagram shown in Figure 3.2. As the piston
reciprocates, fluid in zone one oscillates inside the pump head and several compliance
chambers as well as the ventricular chamber. Zone two consists of the fluid inside the
atrium and aortic chambers, as well as inside the ventricular membrane. As the fluid
in zone one advances inside the pump head during the forward stroke, the ventricular
membrane contracts, providing the driving force for fluid flow inside zone two. [43]

Figure 3.2: Model Heart Fluid Zones
The path of fluid flow in the model heart is controlled though the use of poppet
valves. The prosthetic valve is situated in between the ventricle chamber and the
aortic chamber as shown in Figure 3.3. The poppet valve is placed in between the
atrium chamber and the ventricular chamber (in the tricuspid valve site). As the
pressure inside the ventricular membrane increases during the forward stroke of the
piston, the poppet valve will close, thereby directing fluid through the shunt or diodein-shunt and into the aortic chamber. As the piston begins its reverse stroke and the
pressure inside the ventricle decreases, the poppet valve opens, and fluid from both
the atrium and the aorta begin to fill the ventricular membrane. [43]
Typically, the Pulse Duplicator System is used for the testing of synthetic heart
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valves. In the experiments conducted during this study the objective is somewhat
different. The valve in question is not a traditional mechanical valve, but rather
a fluid diode. Also, the physical location of the diode in a clinical setting would be
inside a Sano shunt connecting the right ventricle to the pulmonary artery. The mock
circulatory system will be used to create physiological pressure waveforms comparable
to those observed inside this Sano shunt.

Figure 3.3: Cross-Sectional View of Model Heart

In order to situate the fluid diodes inside the Pulse Duplicator System, specific
holding fixtures were created for each diode. An illustration of one of these holding
fixtures can be seen in Figure 3.4. The length of the shunts inside the holding fixtures
was set to 30mm, the same length of the shunts used in Sano-Norwood procedures
presently. The lip on the bottom of the holding fixture is designed to fit inside an
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annular silicon seal, as depicted in Figure 3.3. The holding fixture is then seated
inside the aortic root. The aortic standoff is then secured to the aortic root using a
series of thumbscrews. Once these screws are tightened, a watertight seal is achieved.
The diodes themselves were seated in the shunts inside the holding fixtures using an
epoxy specifically designed to bond materials with low surface energy, such as Delrin.

Figure 3.4: Cross-Sectional View of 3.54mm Diameter Shunt Holding Fixture
In order to compare the performance of diodes to that of traditional Sano shunts,
rigid Sano shunts with geometry comparable to the diode holding fixtures were also
machined. The inner diameter of each one of these rigid Sano shunts is equivalent
to an inner diameter of one of the diodes. These rigid Sano shunts also have shunt
lengths of 30mm, thereby maintaining dimensional similitude with its diode-in-shunt
counterpart. A total of three diode holding fixtures as well as three rigid Sano shunts
were machined for experimental use.
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3.2 Data Acquisition
The objective of each of these experiments is to acquire pressure and flowrate data
across the empty shunts as well as the diode-in-shunts. In order to fully understand
how diodes function under varying physiological conditions, experiments are completed under a variety of pressures, flowrates, and frequencies. Afterwards, this data
can be evaluated to determine the dimensionless parameters, the regurgitant fraction,
or the phase lag between pressure difference and flowrate waveforms. However, the
most important conclusions will be drawn from the plots depicting the relationship
between the peak stroke pressure and the total stroke volume. These are the plots
that are used to characterize the performance of the shunts and diodes-in-shunts
across a wide range of pressures and sizes. The purpose of these plots is to provide a
straightforward method for clinicians to choose the proper shunt/diode combination.
Once these pressure/flow plots have been created, the effect that frequency and diode
geometry have on the pressure/flow relationship is then analyzed.
The data acquisition software provided by Vivitro, known as Vivitest, is designed
to monitor, acquire, and analyze the data generated by the Pulse Duplicator System.
Using this software, one can adjust the frequency of the system, monitor the pressure
and flowrate data in real time, as well as design custom voltage waveforms that control
the displacement of the piston. [43]
Instantaneous flow data is acquired through the use of a Carolina Medical SquareWave Electromagnetic Flowmeter. The flowprobe installed just upstream from the
location of the fluid diode as shown in Figure 3.3, transmits a voltage signal proportional to the flowrate of the fluid to the flowmeter. The pressure difference across the
diode is tracked through the use of two pressure transducers, which are attached to
two separate pressure taps on either side of the diode, as illustrated in Figure 3.3.
All the pressure and flow data is then amplified and routed back to an I/O module
and then to a laptop computer, where it is displayed in real time using the Vivitest
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software. Using this information, the transvalvular pressure difference as well as the
regurgitant fraction of a shunt or diode can be calculated once the experiments are
complete. [43]
At the beginning of each test, either a diode is installed in its respective holding
fixture, which is then seated inside the aortic root chamber, or an empty rigid Sano
shunt is simply seated inside the aortic root chamber. A physiologically relevant
frequency is set and the stroke amplitude of the piston is then increased until the
transvalvular pressure difference reaches a magnitude of approximately 3 - 5mmHg.
The acquisition process, which is completed over a period of ten cycles, and uses a
sampling rate of 256 Hz, can then begin. Once the Vivitest software has captured a
series of ten cycles, the acquisition process is repeated twice more at the same stroke
amplitude in order to ascertain a reasonable average of the pressure and flowrate
data.
When testing each diode-in-shunt, the frequency will be held constant as the
stroke amplitude of the piston is increased incrementally until the transvalvular pressure difference reaches the maximum physiological transvalvular pressure difference.
This process is then repeated at several different frequencies in order to assess the
effect frequency has on diode-in-shunt performance. In order to compare the performance of the diodes-in-shunts tested in vitro, to the performance of in vitro Sano
shunts, the pressure differences across both the Sano shunt and diode-in-shunt must
be comparable. The in vivo ventricular and pulmonary artery pressure waveforms
used to construct in vitro waveforms, provided courtesy of the University of Nebraska
Medical Center, can be seen in Figure 3.5 (the original pdf files taken directly from
the heart monitors can be found in figures A.18 and A.19, Appendix A).
It was difficult to construct an in vitro pressure waveform identical to a physiological pressure waveform across a Sano shunt. The main reason for this is that the
Vivitro hardware lacked a real time feedback system capable of altering the piston
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Figure 3.5: Sample In Vivo Pressure Waveforms [14]
motion based on the pressure difference. Thus, the waveforms created for this project
were created using a trial and error procedure. A comparison between the in vivo
and in vitro pressure waveforms can be seen in Figure 3.6.

Figure 3.6: Pressure Comparison Between In Vivo and In Vitro Waveforms; In Vivo
Waveform Provided by UNMC [14]
One concern that arose as the experiments commenced was the issue of random
error in the flowmeter. Because of the small shunt size, measurements were taken at
the low-flow end of the sensor range where the noise can play a factor. In order to
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quantify the level of noise in the flowrate signal, measurements were first taken with
the pump amplitude set to zero. During these tests, the flowmeter should generate
a flowrate signal of zero magnitude. However, due to issues such as offset potential,
electrical interference from other cables, etc. the flowmeter generates some noise that
interferes with the signal. These zero-amplitude tests were performed using both
saline solution and blood analogue. During the saline test, the flowmeter generated
flowrates between -5.9 - 7.6ml/sec. During the blood analogue test, the flowrate
ranged from -4.2 - 4.3ml/sec.
The noise is filtered out using a Gaussian low pass smoothing operator, which uses
a convolution of the flow data in conjunction with a Gaussian distribution in order to
smooth the data. Using a matlab program (displayed in Appendix C), the smoothed
instantaneous flowrate data is then integrated to yield the net flow per cycle, as well
as the total systolic and diastolic stroke volumes. The average systolic and diastolic
stroke volumes for all thirty cycles are then calculated and plotted against the average
peak systolic and diastolic pressures, respectively, in order to illustrate the effects of
frequency and diode geometry. The effect of noise in the flowmeter readings is evident
at lower flowrates especially during experiments conducted using saline as the test
fluid. To identify the effect of noise in the flowmeter, many of the plots that include
flowrate data are fitted with error bars that represent ± one standard deviation of
the thirty averaged stroke volumes.

3.3 Regurgitant Fraction
Using the equation for the dimensionless pressure coefficient, it can be shown that
during steady flow cases, pressure is proportional to the square of velocity. Therefore, power law relationships are one choice when curve fitting the data sets. Results
from a 2002 study detailing the fluid dynamics of in vitro MBT shunts showed that a
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quadratic relationship between pressure and flow existed [44]. By plugging the physiologic systolic or diastolic pressure difference into the corresponding pressure/flow
curve fit, the expected systolic and diastolic volume flow per cycle can be determined.
These two values are then used in the determination of the regurgitant fraction. The
RF% is the parameter used to gauge the performance of the diode. This is the same
parameter that cardiologists use to evaluate the severity of aortic regurgitation. The
equation for the regurgitant fraction may be seen below. [45]

RF% =

Diastolic Stroke Volume
× 100
Systolic Stroke Volume

(3.1)

At the time that these experiments were performed, only one set of in vivo ventricular and pulmonary artery pressure waveforms was available. These in vivo pressure
waveforms were taken from a patient with a heart rate of 99bpm. Assuming that compensatory mechanisms remain unchanged, as heart rate changes, the peak pressure
in both the ventricle and the pulmonary artery is likely to change as well. However,
because no data is available at any other frequency, the RF% calculations will be
performed at the same peak pressures, regardless of frequency change.

3.4 Scaling Laws for Preliminary Experiments
Before blood analogue tests were performed, preliminary tests using saline as
the test fluid were conducted. Due to the different viscosities of blood analogue
and saline, one must perform some dimensional analysis in order to ensure that the
dimensionless parameters of the model and the prototype agree. The dimensionless
parameters used in pulsatile flow problems are the Reynolds number, the Strouhal
number, the Pressure Coefficient, and the aspect ratio. By observing the Reynolds
number and the Strouhal number, it is clear that the factor by which viscosity changes
is equivalent to the factor by which both frequency and velocity must change.
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Reynolds Number : Re =

Du
ν

(3.2)

Strouhal Number : St =

Df
ν

(3.3)

Through the use of the Pressure Coefficient, it can be seen that the pressure
difference is proportional to the square of velocity. Therefore, any change in viscosity
will result in a change in pressure equivalent to the square of that factor.

Pressurel Coefficient : Cp =

∆p
1/2ρu2

(3.4)

The aspect ratios will always remain the same, given that the same holding fixtures
and rigid Sano shunts are used for both the saline and blood analogue experiments.

Chapter 4
Results and Discussion
The performance of three different size diodes-in-shunts was compared to the performance of three empty rigid Sano shunts. The three diodes-in-shunts have shunt
diameters of 7.07mm, 9.69mm, and 11.09mm. The rigid Sano shunts have diameters equal to that of the inner diameters of the diodes-in-shunts, which are 3.54mm,
4.85mm, and 5.55mm, respectively. Each of the holding fixtures and rigid Sano shunts
have a pipe length of 30mm. Experiments were conducted using both saline solution
and blood analogue.

4.1 Preliminary Experiments
Preliminary tests were conducted first using a saline solution as the test fluid,
instead of blood analogue. In order to maintain dimensional similitude, the pressure
range and frequency were both scaled accordingly to account for the difference in
viscosity between blood analogue and saline. This first series of tests was conducted
at a temperature of 23.5°C using a 0.9% NaCl solution with a kinematic viscosity of
9.31 × 10−7 m2 /sec. Experiments were carried out at frequencies of 19bpm, 28bpm,
and 37bpm. These frequencies were scaled from the assumption that a blood analogue
with a kinematic viscosity of 5 × 10−6 m2 /sec would later be used as the test fluid
35
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during experiments at frequencies of 100bpm, 150bpm, and 200bpm. The viscosity of
the saline solution was not actually measured, but rather derived from water viscosity
tables [46].
Experiments were run on all three diodes-in-shunts as well as all three empty
shunts during the first collection of preliminary testing. A basic sinusoidal voltage
waveform was used to control the motion of the piston. This resulted in a similar
looking pressure waveform across each shunt and diode-in-shunt. When normalized
with respect to time the pressure waveforms closely resembled one another at different
frequencies as well. Unfortunately, these pressure waveforms did not closely resemble
the scaled physiological pressure waveform. The amplitude of the in vitro pressure
waveforms during diastole was too large. Fortunately, this issue was only apparent
during the preliminary saline tests. An example of the pressure waveform comparison
can be seen in Figure 4.1.

Figure 4.1: Pressure History Comparison between 5.55mm Empty Shunt and
11.09mm Diode-In-Shunt at 37bpm; Test Fluid: Saline Solution [14]
The testing of each of the three diodes-in-shunts as well as the three rigid Sano
shunts at three different frequencies produced a total of 9 individual case studies
of diode-in-shunt flow, 9 individual case studies of Sano shunt flow, as well as 27
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comparative studies between Sano shunts and diodes-in-shunts. The Womersley and
peak Reynolds numbers for each of the 18 individual cases were calculated and can
be seen in Table 4.1. Both dimensionless parameters for the diode-in-shunt cases
c was calculated using the
were calculated using the inner diameter of the diode. Re
peak systolic flow velocity observed when the pressure difference reached the scaled
physiological peak pressure difference observed in the clinical Sano shunt data. A
diagram of the two dimensionless parameters plotted against one another at the three
different test frequencies can be seen in Figure 4.2.
Table 4.1: Dimensionless Parameters for Preliminary Tests using Saline Solution
Frequency (bpm)
19
28
37
19
28
37
19
28
37
19
28
37
19
28
37
19
28
37

Diameter (mm)
3.54
3.54
3.54
4.85
4.85
4.85
5.55
5.55
5.55
7.07
7.07
7.07
9.69
9.69
9.69
11.09
11.09
11.09

α
2.6
3.1
3.6
3.5
4.3
4.9
4.1
4.9
5.7
5.2
6.3
7.2
7.1
8.6
9.9
8.1
9.8
11.3

c
Re
2054
2214
2263
3060
3117
3219
3454
3575
3923
3139
3207
3257
4680
4873
4833
4719
4786
4767

The peak Reynolds numbers in the Sano shunts ranged from 2054 – 3923 and
increased with increasing frequency. The peak Reynolds numbers in the diodes-inshunts range from 3139 – 4873 and have no clear trend with respect to frequency. This
explains why during the Sano shunt experiments, the peak Reynolds number increases
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as the Womersley number increases, whereas during the diode-in-shunt experiments,
the peak Reynolds number follows no clear trend as the Womersley number increases.
During testing of the Sano shunts, α ranged from 2.6 – 5.7. α values during the diodein-shunt testing were substantially higher, ranging from 5.2 – 11.3. In both the Sano
shunts as well as the diodes-in-shunts α increases with square root of frequency, as
expected.

c vs. α; Test Fluid: Saline; Frequencies: 19bpm, 28bpm, 37bpm
Figure 4.2: Re
As expected, during the Sano shunt experiments, the Reynolds number increases
as the diameter of the shunt increases. However, this trend is not necessarily true
c
when considering diode-in-shunt flow. At frequencies of 28bpm and 37bpm, the Re
is actually higher in the 9.69mm diode-in-shunt than in the 11.09mm diode-in-shunt.
Although the flowrate is greater in the 11.09mm diode-in-shunt during tests at these
two frequencies, the velocity of the fluid is greater in the 9.69mm diode-in-shunt,
c
which in turn increases Re.

4.1.1 Saline Experiments: Instantaneous Pressure and Flowrate
The analysis of the raw pressure and filtered flowrate data begins by addressing the
phase lag that is often present in pulsatile flow. Womersley postulated that in pulsatile
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flows, once α is greater than 1, a substantial phase difference should exist between
the flowrate and pressure difference waveforms, with the flowrate waveform lagging
behind the pressure difference waveform. This phase difference should continue to
grow until it reaches a maximum of 90° once α > 10. The data from the present
study does not appear to support that conclusion. The phase difference does not
appear to follow any trend that is dependent on the Womersley number. In fact, the
largest phase difference (12°) was observed during the testing of the 3.54mm shunt at
a frequency of 19bpm, which resulted in the lowest Womersley number of any test that
was sampled. During many of the experiments, the pressure waveform even lagged
the flowrate waveform. One reason for the discrepancy might be that the shunts used
in these experiments were rather small. As Lighthill demonstrated, flows in vessels
smaller than 4mm in diameter will not exhibit this phase lag. [36]
An example of the phase comparison between a flowrate waveform and pressure
difference waveform can be seen in Figure 4.3. The phase difference between the two
was calculated based on the time separating the peak systolic flowrate and the peak
systolic pressure difference. In over 90% of the preliminary saline tests, the phase
difference was less than 10°.
In order to determine the effect the system frequency has on flowrate, the phase
difference was calculated for the flowrate waveforms at several different frequencies for
each shunt and diode-in-shunt case. Here, the phase difference was calculated based on
the time separating the location of the peak flowrates. The flowrate waveforms taken
from higher frequency (and therefore higher α) experiments always lagged behind the
flowrate waveforms taken from lower frequency experiments. However, the largest
phase difference was only of 11.25° magnitude. An example of the comparisons made
between flowrate waveforms at different frequencies can be seen in Figure 4.4.
As illustrated in Figure 2.8, Womersley demonstrated how the flowrate ratio between the pulsatile flowrate and the steady-state Poiseuille flowrate operating under
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Figure 4.3: Comparison Between Pressure Difference Waveform and Flowrate Waveform, Showing Phase Lag of Flowrate; 11.09mm Diode; Test Fluid: Saline Solution,
Frequency: 37bpm

Figure 4.4: Frequency Effect on Flowrate Waveform: 7.07mm Diode; Test Fluid:
Saline Solution
the same pressure gradient would decrease with increasing α. At first glance, when
comparing different sized shunts and diodes-in-shunts, this appears to be the case.
However, it seems that this trend holds true only while the shunt diameter is increased, and the frequency held constant. When the shunt diameter is held constant,
and the frequency increased, the ratio fluctuates randomly as α increases steadily. In
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flows with α > 10, Womersley demonstrated theoretically that the ratio would be less
than 1:15. The ratio between the Womersley flowrate and the Poiseuille flowrate in
the present study is typically much smaller. For example, during tests in the 4.85mm
diode-in-shunt, where α = 3.5, the ratio was already as low as 1:18.
In order to determine how the time/flowrate relationship is affected by the change
in amplitude of the peak systolic pressure difference, flowrate waveforms from experiments performed on the same shunt or diode-in-shunt were plotted side by side
and examined. These flowrate waveforms were taken from experiments performed
at equivalent frequencies, but different peak pressure difference amplitudes. The
flowrate data was taken from the average of 30 cycles and then normalized with respect to the averaged peak flowrate from those 30 cycles. This process was completed
for each shunt and diode-in-shunt at all three frequencies, to produce a total of 18
data sets, each of which contains 3 normalized flowrate waveforms. An example of
this can be seen in Figure 4.5, where the flowrate waveforms at different peak pressure differences from tests performed on the 11.09mm diode-in-shunt at a frequency
of 28bpm are plotted alongside one another. The peak systolic pressure differences
corresponding to the flowrate waveforms depicted are 0.10mmHg, 1.92mmHg, and
4.3mmHg.
The phase difference between the flowrate waveforms at the different peak pressure differences during systole was almost nonexistent. Most of the phase differences
between the waveforms were as small as 10°, and there appeared to be no correlation
between the amplitude of the peak pressure difference and the phase lag between the
flowrate waveforms during systole. However, during diastole it was observed that
the data taken from the tests performed at lower peak systolic pressure differences
tended to lag the data taken from tests performed at the highest peak systolic pressure difference. This trend occurred in all of the 18 data sets. The degree of phase
difference was also noticeably higher during diastole. Over 75% of the phase lags
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Figure 4.5: Peak Pressure Effect on Time/Flowrate Relationship; 11.09mm Diode;
Frequency: 28bpm Test Fluid: Saline Solution
between waveforms were larger than 10°, with the largest being 49°. Another trend
noticed during diastole has to do with the correlation between the amplitude of the
normalized peak diastolic flowrate and the peak pressure difference. During 12 of the
18 data sets studied, it was noted that as the peak pressure difference increased, the
amplitude of the normalized peak diastolic flowrate decreased.

4.1.2 Saline Experiments: Systolic and Diastolic Volumetric Flow versus
Peak Pressure
An effective display of shunt and diode-in-shunt performance is through the use
of plots depicting the relationship between peak stroke pressure and total stroke
volume. These plots can be used to illustrate the effects of frequency or diode size.
The purpose of these plots is to provide a straightforward method for clinicians to
choose the proper shunt/diode combination.
An example of the comparison between systolic flow in the three shunts and the
three diodes-in-shunts at equivalent frequencies can be seen in Figure 4.6. At all frequencies tested, systolic flow through the nozzle side of the diodes is always greater
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than systolic flow through a Sano shunt of equivalent diameter. As one would expect,
the highest systolic flow is achieved in the 11.09mm diode-in-shunt and the lowest systolic flow is seen in the 3.54mm shunt. The magnitude of the systolic flow through the
9.69mm diode-in-shunt always lies somewhere in between the systolic flow achieved
in the 5.55mm shunt and the 11.09mm diode-in-shunt, whereas the magnitude of the
systolic flow through the 7.07mm diode-in-shunt always lies somewhere in between
the systolic flow of the 3.54mm shunt and the 4.85mm shunt. More of the systolic
flow plots can be found in Figures A.1 and A.2, Appendix A.

Figure 4.6: Size Effects on Pressure/Flow Relationships during Systole at 19bpm;
Test Fluid: Saline Solution
The noise in the flowmeter is much more noticeable when comparing the diastolic
pressure/flow relationships between shunts and diodes-in-shunts. The standard deviation of the volumetric flow per cycle reaches values as high as 1ml in the flowrate
range that preliminary saline tests were performed. Although this noise is present
in the systolic data, it is not nearly as noticeable due to the higher flowrate range
associated with systolic flow. Due to this noise, calculations such as the regurgitant
fraction that are based off this data from the saline tests are less accurate. An example of the issues accompanying diastolic pressure flow relationships can be seen in
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Figure 4.7.

Figure 4.7: Size Effects on Pressure/Flow Relationships during Diastole at 19bpm;
Test Fluid: Saline Solution
By observing Figure 4.7, one can see that it is possible that the noise of the
flowmeter may have compromised the results. At the scaled physiologically relevant
pressure range, there is more diastolic flow in the 9.69mm diode-in-shunt and the
4.85mm Sano shunt than in the 11.09mm diode-in-shunt and 5.55mm Sano shunt,
respectively. Due to the close proximity of the curve fits, the error bars have been left
out of Figure 4.7. They simply clutter the figure with too much information, making
it difficult to interpret. It is also apparent that the curve fits of the smallest shunt
and the smallest diode-in-shunt encompass pressure domains much smaller than the
rest of the curve fits. This is because the diastolic pressure differences and therefore
the diastolic flowrates present in the smaller shunts and diodes-in-shunts do not have
a strong degree of correlation with the stroke volume of the pump. As the stroke
volume of the pump was decreased during testing, the maximum systolic pressure
decreased proportionally. However, the maximum diastolic pressures and flowrates
did not decrease in a similar manner. Only after the stroke volume of the pump
reached a certain threshold, would the diastolic pressure decrease in a proportional
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manner. For this reason, some of the higher data points have been left out in order
to achieve more accurate curve fits. This phenomenon was observed in experiments
performed on each shunt and diode-in-shunt during preliminary saline tests. However,
the threshold was higher in the larger shunts and diodes-in-shunts.
In order to determine the optimal diode size, the regurgitant fraction and the
percentage change in flow from shunt to diode-in-shunt was calculated for each of the
27 cases. But first, the peak pressure values used in these calculations were scaled in
order to account for the change in viscosity. The scaled peak systolic and diastolic
pressures are equal to 2.24mmHg and 0.25mmHg, respectively. The regurgitant fraction of the Sano shunts at these pressures varies from 9.2% to 19.7%, whereas the
regurgitant fraction of the diodes-in-shunts at these pressures ranged from 7.2% to
23.8%.
Of the 27 comparisons that can be made between shunt and diode-in-shunt performance, 15 exhibited lower regurgitant fractions in diodes-in-shunts than in empty
shunts. However, in only 7 of these 15 instances was there any decrease in diastolic
flow volume. In each of the other 8 cases, the increase in systolic flow volume was
large enough to offset the increase in diastolic flow volume, thereby improving upon
the RF%. In only one instance did experiments actually indicate an increase in systolic flow volume as well as a decrease in diastolic flow volume. This occurred during
the comparison between the 3.54mm empty shunt and the 7.07mm diode-in-shunt at
a frequency of 19bpm. In this instance, the systolic flow volume increased by 70.7%
while the diastolic flow volume decreased 4.8%. These improvements resulted in a
decrease in RF% from 12.9% to 7.2%. All of the tabulated results comparing RF%
between shunts and diodes-in-shunts from the saline experiments can be found in
Table B.1, Appendix B.
The effects of frequency on the systolic pressure-flow relationships of a single diodein-shunt at varying frequencies are demonstrated in Figure 4.8. As is illustrated in
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the figure, the systolic volume flow per cycle is inversely proportional to the system
frequency. But, the systolic flowrate should be proportional to the system frequency.
However, at low flowrates, the curve fits do not appear to follow any real trend. This
is a result of the noise present in the flowmeter readings. At higher flowrates, noise is
not as large of a factor, and therefore, the correlation between flowrate and frequency
is easier to distinguish. An example of the problem flowmeter noise presents when
using saline can be seen in Figure A.3, Appendix A.
The effect that the system frequency has on the performance of the diodes-inshunts tested using saline solution is difficult to distinguish. There appears to be no
direct correlation between frequency and regurgitant fraction. As the frequency of
the system was increased during the 4.85mm and 5.55mm Sano shunt experiments, as
well as the 11.09mm diode-in-shunt experiments, the regurgitant fraction appears to
follow no real trend. However, during the testing of the 7.07mm and 9.69mm diodesin-shunts, as well as the 3.54mm Sano shunt, the regurgitant fraction did consistently
increase with increasing frequency.

Figure 4.8: Frequency Effects in 9.69mm Diode-in-Shunt During Systole; Test Fluid:
Saline Solution
The effect that the system frequency has on the percentage change in flow when
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interchanging a shunt with a diode-in-shunt was also studied. There appears to be
no correlation between system frequency and the percentage increase in systolic flow
between shunt and diode-in-shunt combinations. However, there may be a correlation between frequency and diastolic flow change. In all 12 comparison studies of
the 7.07mm and 9.69mm diodes-in-shunts with all three shunts, the percentage decrease of diastolic flow from the shunt to the diode-in-shunt diminished as frequency
increased. In general, the 7.07mm and 9.69mm diodes-in-shunts performed worse at
higher frequencies, whereas the performance of the 11.09mm diode-in-shunt appears
to be independent of frequency.
Although there are 15 cases during the saline testing where replacement of a
certain size shunt with a particular diode-in-shunt arrangement would lead to a lower
regurgitant fraction, these diodes-in-shunts would not be truly beneficial. The lower
RF% are simply a result of either a large increase in systolic flow accompanied by a
large increase in diastolic flow or a large decrease in systolic flow accompanied by a
large decrease in diastolic flow. Any of these scenarios would serve to either overload
the right ventricle with too much retrograde blood flow during diastole or deprive the
lungs of the proper amount of blood flow.

4.2 Blood Analogue Experiments
The bulk of the shunt and diode-in-shunt tests were conducted with blood analogue created using a 55/45-volume mixture of saline and reagent grade glycerin. The
viscosity was measured using an AR1500ex rheometer supplied by TA instruments.
Both the viscosity testing and the experiments performed in the mock circulatory
system were completed at a temperature of 24.5°C. The kinematic viscosity of this
particular solution was equal to 4.9 × 10−6 m2 /sec, which is 5.27 times larger than
that of the saline solution. Because this factor is slightly larger than anticipated,
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the frequencies to be used during the blood analogue experiments were recalculated
using the Strouhal number. Therefore, the shunts and diodes-in-shunts were tested
at frequencies of 100bpm, 148bpm, and 195bpm instead of the projected frequencies
of 100bpm, 150bpm, and 200bpm.
The same basic sinusoidal waveform used to control the motion of the piston in
the preliminary tests was used during the blood analogue tests. Once again, at any
given frequency, the piston motion generated similar pressure waveforms no matter
which shunt or diode-in-shunt was situated in the mock circulatory system. Each of
these pressure waveforms closely resembled the in vivo pressure waveform provided
by UNMC. A comparison of the pressure waveforms can be seen in Figure 4.9.

Figure 4.9: In Vivo and In Vitro Pressure History Comparison at Approximately
100bpm; Test Fluid: Blood Analogue
The same 18 individual case studies of Sano shunt flow and diode-in-shunt flow
as well as the same 27 comparisons between shunt and diode-in-shunt performances
that were made during the preliminary tests were made during the blood analogue
experiments. This time, the dimensionless parameters and regurgitant fractions were
calculated based off the actual peak pressures observed in the in vivo pressure waveforms. The peak systolic and diastolic pressures in these waveforms are 62mmHg and
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7mmHg, respectively. The Womersley and peak Reynolds numbers for each of the 18
individual blood analogue experiments were calculated and can be seen in Table 4.2.
A diagram of the two dimensionless parameters plotted against one another at three
different frequencies can be seen in Figure 4.10.
Table 4.2: Dimensionless Parameters for Preliminary Tests using Blood Analogue
Frequency (bpm)
100
148
195
100
148
195
100
148
195
100
148
195
100
148
195
100
148
195

Diameter (mm)
3.54
3.54
3.54
4.85
4.85
4.85
5.55
5.55
5.55
7.07
7.07
7.07
9.69
9.69
9.69
11.09
11.09
11.09

α
2.6
3.1
3.6
3.5
4.3
4.9
4.1
4.9
5.7
5.2
6.3
7.2
7.1
8.6
9.9
8.1
9.8
11.3

c
Re
1897
1917
1938
2838
2811
2776
3348
3257
3179
2773
2724
2668
4296
4304
4313
4070
4110
4168

Because the Womersley number simply involves adjusting the frequency of the
system to account for the change in viscosity, the Womersley numbers from the saline
tests are identical to the Womersley numbers from the blood analogue tests. There is
little to no error in the scaling because frequency and size are easily measured. The
Reynolds number however, is dependent on velocity, which is calculated based on the
flowmeter readings, which as discussed in section 3.2, are subject to a good deal of
noise. This may partially explain why the Reynolds numbers of the saline tests differ
from the Reynolds numbers from the blood analogue tests.
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c vs. α; Test Fluid: Blood Analogue; Frequencies: 100bpm, 148bpm,
Figure 4.10: Re
195bpm
c in the Sano shunts ranges from 1897 – 3348,
During blood analogue tests, Re
c in the diodes-in-shunts ranges from 2668 - 4313. There does not appear
whereas Re
c During the testing of the 3.54mm
to be any correlation between frequency and Re.
c increases as frequency is increased. However, during the testing of the
shunt, Re
c decreases as frequency is increased. The exact opposite
other two empty shunts, Re
c in diode-in-shunt
trend can be seen when analyzing the effect frequency has on Re
c decreases as frequency is increased in the 7.07mm diode-in-shunt, whereas
flow. Re
c increases as frequency is increased in the 9.69mm and 11.09mm diodes-in-shunts.
Re

4.2.1 Blood Analogue Experiments: Instantaneous Pressure and Flowrate
The phase difference between the pressure difference and flowrate waveforms again
seems to be nonexistent during blood analogue testing. An example of the two waveforms from a blood analogue test on a 11.09mm diode-in-shunt can be seen in Figure
4.11. In over 86% of the blood analogue trials, the phase difference was less than 5°.
When studying the effect frequency has on flowrate during the blood analogue trials, it is evident that the flowrate waveforms taken from higher frequency experiments
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Figure 4.11: Comparison Between Between Pressure Difference and Flowrate Data,
Showing Phase Lag of Flowrate; 11.09mm Diode, Test Fluid: Blood Analogue, Frequency: 37bpm
continuously lag behind the flowrate waveforms taken from lower frequency experiments. The phase lag was more prevalent during the blood analogue trials compared
to the saline trials; the largest phase difference between two flowrate waveforms was
39.4°. An example of the comparisons made between flowrate waveforms at different
frequencies can be seen in Figure 4.12.

Figure 4.12: Frequency Effect on Flowrate Waveform: 9.69mm Diode; Test Fluid:
Blood Analogue

52
When comparing the ratio between the steady-state Poiseuille flowrate to the
pulsatile flowrate operating under the same pressure gradient, the same trends can be
seen that were first observed in the preliminary saline data. The flowrate ratio should
decrease with increasing α, which it appears to do when the diameter is increased and
the frequency held constant. When the diameter is held constant and the frequency
increased, α increases as the flowrate ratio fluctuates. In the blood analogue tests the
ratio from the Poiseuille flowrate to the pulsatile flowrate is also much smaller than
predicted by Womersley.
The correlation between the time/flowrate waveform and the amplitude of the
peak systolic pressure difference from the experiments performed with blood analogue was also studied. The same acquisition process utilized in the saline tests was
used during the blood analogue tests. An example of the comparison made during the
blood analogue trials can be seen in Figure 4.13. The peak systolic pressure difference
was varied over 110mmHg and again, there was essentially no phase difference between the flowrate waveforms during the systolic phase. There was also no noticeable
phase difference between the flowrate waveforms during diastole, as there was during
the saline tests. The correlation between the amplitude of the normalized diastolic
flowrate and the peak pressure difference may still be present in the blood analogue
experiments. In 11 of the 18 data sets studied, as the peak pressure difference was
increased, the amplitude of the normalized peak diastolic flowrate decreased. And in
14 of the 18 data sets, the case with the lowest peak pressure difference exhibited the
largest normalized peak diastolic flowrate.

4.2.2 Blood Analogue Experiments: Systolic and Diastolic Volumetric
Flow versus Peak Pressure
As discussed in Sections 3.2 and 4.1.2, the relationship between peak stroke pressure and total stroke volume is an effective way to characterize the performance of
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Figure 4.13: Peak Pressure Effect on Flowrate Waveforms; 11.09mm Diode; Frequency: 100bpm; Test Fluid: Blood Analogue
an empty shunt or a diode-in-shunt. An illustration of this relationship during systole can be seen in Figure 4.14. The effect that shunt or diode geometry has on
the systolic pressure/flow relationships during the preliminary testing is also evident
during blood analogue testing. Once again, at all frequencies, systolic flow through
the diodes-in-shunts was always higher than systolic flow through the Sano shunts of
equivalent diameter. At 62mmHg, systolic flow was highest in the 11.09mm diode-inshunt, and lowest in the 3.54mm Sano shunt. The curve fit for systolic flow through
the 9.69mm diode-in-shunt always lies somewhere in between the curve fit for the
5.55mm Sano shunt and the 11.09mm diode-in-shunt, whereas the curve fit for systolic flow through the 7.07mm diode-in-shunt always lies somewhere in between the
curve fit for the 3.54mm Sano shunt and the 4.85mm Sano shunt. More systolic pressure/flow plots at different frequencies can be found in Figures A.4 and A.5, Appendix
A.
When blood analogue is used in place of saline solution as the test fluid, the noise
from the flowmeter is not as great of a concern because the flowrate range is much
higher. Even more, during blood analogue experiments, the noise from the flowmeter
decreases compared to the noise observed during the preliminary saline experiments.
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Figure 4.14: Size Effects on Pressure/Flow Relationship during Systole at 195bpm;
Test Fluid: Blood Analogue
This can be seen in the lower standard deviations of the volume flows per cycle.
The largest of these during blood analogue trials is 0.33ml, which is 67% lower than
the value observed during the saline trials. However, the majority of diastolic blood
analogue data sets could not be accurately curve fitted with a power law relationship.
Most of the data sets were linearly interpolated from one data point to the adjoining
data point.
Although the diastolic pressure/flow relationships do not follow power laws, the
diastolic data points from each shunt and diode-in-shunt from the blood analogue
experiments are at least distinguishable from one another, unlike the diastolic curve
fits from the saline experiments. In general, the magnitude of diastolic flow follows
the same order seen in both the saline and blood analogue tests during systole. An
example of this can be seen in Figure 4.15. The comparison between shunts and
diodes-in-shunts at frequencies of 148bpm and 195bpm can be seen in Appendix A,
Figures A.6 and A.7, respectively.
Only at a system frequency of 195bpm are the pressure/flow curve fits not in the
same order as shown in Figure 4.15. In this instance, there is slightly more diastolic
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Figure 4.15: Size Effects on Pressure/Flow Relationship during Diastole at 100bpm;
Test Fluid: Blood Analogue
flow in the 9.69mm diode-in-shunt than in the 11.09mm diode-in-shunt. However,
this could be a result of flowmeter error, because both sets of data in this pressure
range are well within the error bars of the opposite data set.
During the blood analogue experiments, the regurgitant fraction of the Sano
shunts at peak systolic and diastolic pressures varied from 1.1% to 11.9%, whereas
the regurgitant fraction of the diodes-in-shunts at the same pressure gradient ranged
from 6.3% to 16.6%. All of the RF% values from the blood analogue experiments
performed on shunts and diodes-in-shunts can be found in Table 4.3. Of the 27 shunt
to diode-in-shunt comparisons that can be made, only in three cases were there lower
regurgitant fractions in diodes-in-shunts than in empty shunts. In each of these three
instances, a decrease in diastolic flow as well as an decrease in systolic flow was observed when the diode was installed in the shunt. These three cases occurred when
comparing the 7.07mm diode-in-shunt to the 4.85mm and 5.55mm Sano shunts. All of
the tabulated results from the blood analogue trials comparing RF% and percent flow
differences between shunts and diodes-in-shunts can be found in Table B.2, Appendix
B.
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Table 4.3: RF% for each Sano Shunt and Diode-in-Shunt from the Blood Analogue
Trials
Geometry
3.54mm Sano Shunt
3.54mm Sano Shunt
3.54mm Sano Shunt
4.85mm Sano Shunt
4.85mm Sano Shunt
4.85mm Sano Shunt
5.55mm Sano Shunt
5.55mm Sano Shunt
5.55mm Sano Shunt
7.07mm Diode
7.07mm Diode
7.07mm Diode
9.69mm Diode
9.69mm Diode
9.69mm Diode
11.09mm Diode
11.09mm Diode
11.09mm Diode

Frequency (bpm)
195
148
100
195
148
100
195
148
100
195
148
100
195
148
100
195
148
100

RF%
1.33%
2.60%
5.44%
4.12%
7.00%
10.62%
3.33%
6.13%
11.09%
8.65%
6.29%
7.86%
10.28%
12.40%
15.04%
9.45%
11.47%
15.63%

As with the saline experiments, the volume flow per cycle is inversely proportional
to system frequency. This can be seen in the pressure/flow relationship plots at
varying frequencies shown in Figures A.8 - A.13, Appendix A. However, the effect
that the frequency has on the raw flowrate is more easily interpreted during blood
analogue experiments than saline solution experiments. By looking at any number of
pressure/flowrate plots at varying frequencies using blood analogue, it can be deduced
that the systolic flowrate of the system is proportional to the system frequency. An
example of this can be seen in Figure 4.16. The error bars have been left out in order
to avoid cluttering the diagram.
The effect that the system frequency has on the performance of the diodes-inshunts tested using blood analogue is much easier to distinguish than that of saline
experiments. As the system frequency increased, the RF% of both shunts and diodes-
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Figure 4.16: Frequency Effect on Systolic Flowrate; 9.69mm Diode-in-Shunt
in-shunts decreased in in the vast majority of cases. In only one instance, the testing
of the 7.07mm diode-in-shunt did the RF% increase as the frequency was increased
from 148bpm to 195bpm.
There appears to be no correlation between system frequency and the percentage
increase in systolic flow between shunt and diode-in-shunt combinations during blood
analogue experiments. However, a correlation between frequency and diastolic flow
change does seem to exist. In 16 out of the 18 comparison studies between shunt and
diode-in-shunt performance, the percentage decrease of diastolic flow from the shunt
to the diode-in-shunt diminished as frequency increased.
There were only 4 cases during the blood analogue trials where diode-in-shunt tests
produced lower RF% than empty shunt tests, compared to 15 cases exhibited during
the saline tests. Once again, the lower regurgitant fractions are merely an indication
that the current sizes of diodes-in-shunts are only capable of either increasing systolic
flow while proving inept at decreasing diastolic flow, or capable of decreasing diastolic
flow while proving inept at increasing systolic flow. For example, although compared
to an empty 4.85mm Sano shunt, either the 9.7mm or 11.09mm diode-in-shunt would
increase the percentage of systolic blood flow at least 50%, the resulting increase
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in diastolic flow of at least 110% to the right ventricle would defeat the purpose of
installing a diode in the first place. As with the preliminary saline tests, the results
from the blood analogue experiments indicate that there is not a performance gain
when any of the three different sizes of diodes are installed inside an empty shunt.

4.3 Blood Analogue Trials with Diode set in Shunt Entrance
In steady-state flow, the pressure coefficient decays exponentially as a function
of the rounding of the inlet edge [47]. In an effort to improve entrance effects, the
fluid diode was repositioned at the entrance of the shunt, which will henceforth be
referred to as location 2. With the diodes positioned at location 2, the diode-in-shunt
experiments for each of the three diodes were repeated at the same three frequencies of the original blood analogue trials (100bpm, 148bpm, and 195bpm). These
experiments were completed using blood analogue of the same composition as before
(55/45) at a temperature of 24.5°C. The viscosity of this new solution at 24.5°C was
4.82 × 10−6 m2 /sec. Although this differs slightly from the viscosity of the solution
used in the early set of blood analogue experiments, it is within the 3% margin of
error of the rheometer. Therefore, the empty Sano shunt results from the original
blood analogue trials can be used for comparison. Also, no scaling adjustments need
to be made to the frequency of the new experiments. The pressure waveforms observed were very similar in phase and amplitude to the pressure waveforms exhibited
in empty shunt flow and in vivo. A comparison of the pressure waveforms can be seen
in Figure 4.17.
Once again, the dimensionless parameters and regurgitant fractions were calculated based off the actual peak pressures observed in the in vivo pressure waveforms. The peak systolic and diastolic pressures in these waveforms are 62mmHg and
7mmHg, respectively. The Womersley and peak Reynolds numbers for each of the
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Figure 4.17: In Vivo and In Vitro Pressure History Comparison at Approximately
100bpm with Diodes Placed in Entrance of Shunt; Test Fluid: Blood Analogue
new 9 individual blood analogue experiments were calculated and can be seen in Table 4.4 alongside the same dimensionless parameters from the original blood analogue
tests. A diagram of the two dimensionless parameters plotted against one another at
three different frequencies can be seen in Figure 4.18. During these tests, there is no
change in α compared to the α’s from the original blood analogue tests. However,
c increases as
due to the enhanced entrance effects, the velocity increases, therefore Re
c ranges from 2899 - 4695. As before, frequency
well. With the diode repositioned, Re
c Re
c decreases as frequency is increased in the 7.07mm
has no discernible effect on Re.
c increases as frequency is increased in the
and 11.09mm diodes-in-shunts whereas Re
9.69mm diode-in-shunt.

4.3.1 Blood Analogue Trials with Diode set in Shunt Entrance: Instantaneous Pressure and Flowrate
With the diode repositioned, the phase difference between the pressure difference
and flowrate waveforms again seems to be nonexistent. The vast majority of the phase
differences were less than 10°. The flowrate waveforms taken from higher frequency
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c vs. α; Test Fluid: Blood Analogue; Frequencies: 100bpm, 148bpm,
Figure 4.18: Re
195bpm; Diode set in Shunt Entrance
Table 4.4: Dimensionless Parameter Comparison between Diodes-in-Shunts Positioned at Location 1 and Location 2; Test Fluid: Blood Analogue
Diode Diameter (mm)
7.07
7.07
7.07
9.69
9.69
9.69
11.09
11.09
11.09

Frequency (bpm)
195
148
100
195
148
100
195
148
100

α
5.2
6.3
7.2
7.1
8.6
9.9
8.1
9.9
11.3

c Location 1
Re
2773
2724
2668
4296
4304
4313
4070
4110
4168

c Location 2
Re
2899
3043
3066
4695
4691
4651
4548
4551
4593

experiments still consistently lag behind the flowrate waveforms taken from lower
frequency experiments. The largest phase difference between two flowrate waveforms
with the diodes positioned at the shunt entrance was 40.8°, only slightly larger the
the largest phase difference between two flowrate waveforms from the earlier blood
analogue trials. The repositioning of the diode seems to also have no effect on the
trends concerning the ratio between the steady-state Poiseuille flowrate to the pulsatile flowrate operating under the same pressure gradient. The flowrate ratio should
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decrease with increasing α, which it appears to do so when the diameter is increased
and the frequency held constant. When the diameter is held constant and the frequency increased, the ratio between the flowrates fluctuates randomly as α increases.
The final analysis of the raw data has to do with the effect the amplitude of
the peak systolic pressure difference has on the time/flowrate waveform. The same
acquisition process utilized in the earlier blood analogue tests was used here. The
flowrate waveforms were taken from tests completed on a diode-in-shunt at the the
same frequency, but different peak systolic pressure differences. The flowrate data
was taken from the average of 30 cycles and then normalized with respect to the
averaged peak flowrate from those 30 cycles. The peak pressure difference was varied
over approximately 70mmHg. There was not a discernible phase difference between
any of the waveforms during either systole or diastole. The correlation between
the amplitude of the normalized diastolic flowrate and the peak pressure difference
was still noticeable. During only 5/9 data sets studied, did the amplitude of the
normalized peak diastolic flowrate increase as the peak systolic pressure difference
decreased. However, in each of the nine data sets, the waveform corresponding to
the lowest peak systolic pressure difference also exhibited the largest normalized peak
diastolic flowrate amplitude.

4.3.2 Blood Analogue Trials with Diode set in Shunt Entrance: Systolic
and Diastolic Volumetric Flow versus Peak Pressure
In order to visualize the improved results gained by moving the diode from the
middle of the shunt to the entrance, one can observe the relationship between the
peak stroke pressure difference and stroke volume. The relationship between peak
systolic pressure difference and systolic stroke volume can be seen in Figure 4.19.
At all frequencies, at the peak in vivo systolic pressure (62mmHg) there is always
more forward flow in the diode-in-shunt at location 2 than there is in the diode-in-
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shunt at location 1. At a peak systolic pressure of 62mmHg, the diodes-in-shunts at
location 2 exhibited anywhere from a 2.3% - 20.5% increase in systolic flow compared
to the systolic flow observed in diodes-in-shunts at location 1. In general, the largest
improvements in systolic flow were observed at higher frequencies.

Figure 4.19: Comparison Between Systolic Diode Performance based on Diode Placement; Frequency: 195bpm; Test Fluid Blood Analogue
Although the diode repositioning was only designed to improve the entrance effects, the diastolic flow through the diodes was actually enhanced more so than the
systolic flow. At the peak in vivo diastolic pressure (7mmHg), the diodes-in-shunts
at location 2 exhibited anywhere from an 8.4% - 41.4% reduction in diastolic flow
compared to the diastolic flow observed in diodes-in-shunts at location 1. This improvement in diastolic flow can be visualized in Figure 4.20.
These improvements during both strokes of the cardiac cycle result in considerable
improvements in the RF%. The percent decrease of the RF% as a result of the location
change ranges from 11 - 51%. The comparison between RF% of the diodes-in-shunts
at each location can be seen in Table 4.5. All of the tabulated results from these
experiments can be found in Table B.3, Appendix B.
Although the repositioning of the diode does result in increased performance in all
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Figure 4.20: Comparison Between Diastolic Diode Performance based on Diode Placement; Frequency: 148bpm; Test Fluid Blood Analogue
Table 4.5: RF% Comparison between Diodes-in-Shunts Positioned at Location 1 and
Location 2; Test Fluid: Blood Analogue
Diode Diameter (mm)
7.07
7.07
7.07
9.69
9.69
9.69
11.09
11.09
11.09

Frequency (bpm)
195
148
100
195
148
100
195
148
100

RF% Location 1
8.65%
6.29%
7.86%
10.28%
12.40%
15.04%
9.45%
11.47%
15.63%

RF% Location 2
4.21%
4.55%
7.01%
7.96%
9.09%
11.95%
8.16%
8.28%
11.51%

three diodes-in-shunts, there still was not one instance where the diode installation
resulted in a performance gain. However, this study was performed using only three
different sizes of diodes. Although no performance gain is evident using these particular size diodes, that is not to say that a different size fluid diode cannot outperform an
empty shunt. By inspecting Figures 4.21 and 4.22, one can see that the systolic flow
of the 7.07mm diode-in-shunt is nearly equal to that of the 4.85mm empty shunt, and
yet the diastolic flow is substantially less. The 9.69mm and 11.09mm diodes-in-shunts
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permit too much diastolic flow, and therefore should not be considered as viable options. This would lead one to believe that a diode-in-shunt with an outer diameter in
between 7.07mm - 9.69mm could produce the ideal combination of systolic/diastolic
flow. This diode/shunt combination would likely improve upon the RF% currently
experienced in a Sano shunt of 5mm diameter. The remaining plots detailing the
relationship between pressure and flow in the diodes-in-shunts with the diode placed
at the shunt entrance can be seen in Figures A.14 - A.17, Appendix A.

Figure 4.21: Size Effects on Pressure/Flow Relationship during Systole at 148bpm;
Diode Location: Shunt Entrance; Test Fluid: Blood Analogue
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Figure 4.22: Size Effects on Pressure/Flow Relationship during Diastole at 148bpm;
Diode Location: Shunt Entrance; Test Fluid: Blood Analogue

Chapter 5
Conclusion
The Sano-Norwood procedure is the first of three palliative surgical procedures
performed on infants with hypoplastic left heart syndrome. Although the implementation of the Sano shunt has been shown to resolve the issue of coronary steal that is
present inside the modified Blalock-Taussig shunt, the regurgitant blood flow present
during diastole can overload the ventricle, leading to myocardial hypertrophy. The
purpose of the present study was to determine whether a fluid diode installed inside
the Sano shunt could either maintain or increase systolic flow while inhibiting diastolic
regurgitation.
Tests were first performed with a diode situated in the middle of an empty shunt
using both saline solution and blood analogue. The performance of each diode-inshunt was compared to the performance of each empty shunt. Both sets of experiments
indicated that with this current combination of shunts and diodes-in-shunts that lower
RF% can be achieved by installing a diode in a Sano shunt, however, it typically would
result in either a decrease in systolic flow or an increase in diastolic flow. Either one of
these changes would be detrimental to the patient. The next set of experiments were
conducted with the diode positioned at the entrance to the shunt. This repositioning
of the diode led to improvements in both systolic and diastolic flow, which in turn
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resulted in anywhere from an 11% - 51% decrease in RF%. If a diode is to be installed
in a Sano shunt, it should clearly be placed at the entrance to the shunt instead of in
the middle.
Unfortunately, these improvements did not yield a single case of a diode-in-shunt
that exhibited equal systolic flow and less diastolic flow when compared to any of
the three empty shunts. This being said, the number of diodes available for testing
was rather limited. These experiments should be repeated with several new diodes of
different sizes. By observing the systolic and diastolic pressure/flow plots from the
final set of blood analogue experiments, one can see that the ideal diode size likely
lies somewhere in between 7.07mm - 9.69mm. A diode of this size, situated in the
entrance of an empty shunt would likely produce more systolic flow and less diastolic
flow than a 5mm empty shunt.

5.1 Future Work
The most obvious continuation of this research would be the fabrication and experimental testing of several different size diodes-in-shunts. The optimal size diode
would have an outer diameter in between 7.07mm and 9.69mm. In order to more
accurately determine the effect frequency has on the performance of the diodes-inshunts, the calculation of the RF% of diodes-in-shunts tested at a certain frequency
should be performed using in vivo data of the same frequency. Conventional wisdom
would suggest that as the frequency changes, so should the pressure difference across
the shunt, as well as the flowrate through the shunt. In order to do this, more in
vivo data is required. Another improvement upon this study would be the addition
of a real time feedback system that would adjust the motion of the piston based
on the pressure difference. This would result in a more accurate depiction of the
in vivo pressure difference waveform. Another interesting addition may also be the
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calculation of the decreased workload on the right ventricle as a result of the diode
installation. The work performed by the ventricle is determined using the integral of
both the instantaneous pressure and flowrate measurements [26].
Z
W=

P(t) · Q(t) · dt

(5.1)
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Appendix A
Figures

Figure A.1: Size Effects on Pressure/Flow Relationships during Systole at 28bpm;
Test Fluid: Saline Solution
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Figure A.2: Size Effects on Pressure/Flow Relationships during Systole at 37bpm;
Test Fluid: Saline Solution

Figure A.3: Frequency Effect on Systolic Pressure/Flowrate Relationships in 9.69mm
Diode; Test Fluid: Saline Solution
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Figure A.4: Size Effects on Pressure/Flow Relationships during Systole at 100bpm;
Test Fluid: Blood Analogue

Figure A.5: Size Effects on Pressure/Flow Relationships during Systole at 148bpm;
Test Fluid: Blood Analogue
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Figure A.6: Size Effects on Pressure/Flow Relationship during Diastole at 148bpm;
Test Fluid: Blood Analogue

Figure A.7: Size Effects on Pressure/Flow Relationship during Diastole at 195bpm;
Test Fluid: Blood Analogue
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Figure A.8: Frequency Effects on Pressure/Flow Relationships during Systole in 3.54
Sano Shunt; Test Fluid: Blood Analogue

Figure A.9: Frequency Effects on Pressure/Flow Relationships during Systole in 4.85
Sano Shunt; Test Fluid: Blood Analogue
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Figure A.10: Frequency Effects on Pressure/Flow Relationships during Systole in
5.55 Sano Shunt; Test Fluid: Blood Analogue

Figure A.11: Frequency Effects on Pressure/Flow Relationships during Systole in
7.07mm Diode; Test Fluid: Blood Analogue
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Figure A.12: Frequency Effects on Pressure/Flow Relationships during Systole in
9.69mm Diode; Test Fluid: Blood Analogue

Figure A.13: Frequency Effects on Pressure/Flow Relationships during Systole in
11.09mm Diode; Test Fluid: Blood Analogue
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Figure A.14: Size Effects on Pressure/Flow Relationship during Systole at 100bpm;
Diode Location: Shunt Entrance; Test Fluid: Blood Analogue

Figure A.15: Size Effects on Pressure/Flow Relationship during Diastole at 100bpm;
Diode Location: Shunt Entrance; Test Fluid: Blood Analogue
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Figure A.16: Size Effects on Pressure/Flow Relationship during Systole at 195bpm;
Diode Location: Shunt Entrance; Test Fluid

Figure A.17: Size Effects on Pressure/Flow Relationship during Diastole at 195bpm;
Diode Location: Shunt Entrance; Test Fluid: Blood Analogue
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Figure A.18: In Vivo Ventricular Pressure Waveform Observed in Patient Post Norwood Procedure

Figure A.19: In Vivo Pulmonary Arterial Pressure Waveform Observed in Patient
Post Norwood Procedure

Appendix B
Tables
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Table B.1: Statistics for Preliminary Tests using Saline Solution
Shunt
Frequency
Diameter
(bpm)
(mm)

Diode
Diameter
(mm)

37
28
19
37
28
19
37
28
19
37
28
19
37
28
19
37
28
19
37
28
19
37
28
19
37
28
19

7.07
7.07
7.07
9.69
9.69
9.69
11.09
11.09
11.09
7.07
7.07
7.07
9.69
9.69
9.69
11.09
11.09
11.09
7.07
7.07
7.07
9.69
9.69
9.69
11.09
11.09
11.09

3.54
3.54
3.54
3.54
3.54
3.54
3.54
3.54
3.54
4.85
4.85
4.85
4.85
4.85
4.85
4.85
4.85
4.85
5.55
5.55
5.55
5.55
5.55
5.55
5.55
5.55
5.55

Percent
Increase
in
Forward
Flow (%)
55.85
46.27
70.70
188.02
190.75
230.63
250.64
241.04
287.83
-19.20
-24.18
-21.69
49.33
50.72
51.68
81.79
76.79
77.92
-42.14
-43.51
-41.49
6.94
12.29
13.32
30.19
31.71
32.92

Percent
Decrease
in
Reverse
Flow (%)
-47.21
-6.95
4.87
-398.19
-313.25
-245.20
-175.94
-200.46
-247.95
21.57
62.71
65.07
-165.43
-44.11
-26.76
-47.02
-4.78
-27.78
26.75
40.35
61.28
-147.88
-130.48
-40.51
-37.30
-67.57
-41.64

Shunt
RF%

Diode
RF%

13.8
13.3
12.9
13.8
13.3
12.9
13.8
13.3
12.9
13.4
19.7
16.2
13.4
19.7
16.2
13.4
19.7
16.2
10.3
9.2
10.9
10.3
9.2
10.9
10.3
9.2
10.9

13.0
9.7
7.2
23.8
18.9
13.5
10.8
11.7
11.6
13.0
9.7
7.2
23.8
18.9
13.5
10.8
11.7
11.6
13.0
9.7
7.2
23.8
18.9
13.5
10.8
11.7
11.6
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Table B.2: Statistics for Tests using Blood Analogue; Diode Location: Middle of
Shunt
Shunt
Frequency
Diameter
(bpm)
(mm)

Diode
Diameter
(mm)

195
148
100
195
148
100
195
148
100
195
148
100
195
148
100
195
148
100
195
148
100
195
148
100
195
148
100

7.07
7.07
7.07
9.69
9.69
9.69
11.09
11.09
11.09
7.07
7.07
7.07
9.69
9.69
9.69
11.09
11.09
11.09
7.07
7.07
7.07
9.69
9.69
9.69
11.09
11.09
11.09

3.54
3.54
3.54
3.54
3.54
3.54
3.54
3.54
3.54
4.85
4.85
4.85
4.85
4.85
4.85
4.85
4.85
4.85
5.55
5.55
5.55
5.55
5.55
5.55
5.55
5.55
5.55

Percent
Increase
in
Forward
Flow (%)
35.47
44.60
45.19
179.97
179.70
182.38
206.45
206.69
209.25
-25.57
-21.49
-23.27
53.83
51.86
49.24
68.38
66.51
63.44
-42.07
-41.40
-42.77
19.73
13.35
11.31
31.06
24.28
21.91

Percent
Decrease
in
Reverse
Flow (%)
-779.23
-249.22
-109.72
-2058.42
-1231.17
-680.39
-2072.48
-1250.76
-787.76
-56.43
29.42
43.17
-284.02
-169.05
-111.47
-286.52
-173.01
-140.56
-50.65
39.88
59.43
-269.83
-129.17
-50.97
-272.24
-132.54
-71.74

Shunt
RF%

Diode
RF%

1.33
2.60
5.44
1.33
2.60
5.44
1.33
2.60
5.44
4.12
7.00
10.62
4.12
7.00
10.62
4.12
7.00
10.62
3.33
6.13
11.09
3.33
6.13
11.09
3.33
6.13
11.09

8.65
6.29
7.86
10.28
12.40
15.04
9.45
11.47
15.63
8.65
6.29
7.86
10.28
12.40
15.04
9.45
11.47
15.63
8.65
6.29
7.86
10.28
12.40
15.04
9.45
11.47
15.63
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Table B.3: Statistics for Tests using Blood Analogue; Diode Location: Middle of
Shunt
Shunt
Frequency
Diameter
(bpm)
(mm)

Diode
Diameter
(mm)

195
148
100
195
148
100
195
148
100
195
148
100
195
148
100
195
148
100
195
148
100
195
148
100
195
148
100

7.07
7.07
7.07
9.69
9.69
9.69
11.09
11.09
11.09
7.07
7.07
7.07
9.69
9.69
9.69
11.09
11.09
11.09
7.07
7.07
7.07
9.69
9.69
9.69
11.09
11.09
11.09

3.54
3.54
3.54
3.54
3.54
3.54
3.54
3.54
3.54
4.85
4.85
4.85
4.85
4.85
4.85
4.85
4.85
4.85
5.55
5.55
5.55
5.55
5.55
5.55
5.55
5.55
5.55

Percent
Increase
in
Forward
Flow (%)
63.28
59.13
48.46
198.82
205.32
205.77
225.36
224.93
224.35
-10.29
-13.60
-21.54
64.18
65.77
61.60
78.77
76.41
71.42
-30.17
-35.51
-41.48
27.79
23.73
20.53
39.14
31.67
27.86

Percent
Decrease
in
Reverse
Flow (%)
-415.25
-177.74
-91.04
-1684.19
-965.57
-571.05
-1890.53
-932.24
-585.71
8.33
43.87
48.23
-217.44
-115.37
-81.84
-254.15
-108.63
-85.81
11.72
52.19
63.04
-205.71
-83.44
-29.81
-241.06
-77.70
-32.65

Shunt
RF%

Diode
RF%

1.33
2.60
5.44
1.33
2.60
5.44
1.33
2.60
5.44
4.12
7.00
10.62
4.12
7.00
10.62
4.12
7.00
10.62
3.33
6.13
11.09
3.33
6.13
11.09
3.33
6.13
11.09

4.21
4.55
7.01
7.96
9.09
11.95
8.16
8.28
11.51
4.21
4.55
7.01
7.96
9.09
11.95
8.16
8.28
11.51
4.21
4.55
7.01
7.96
9.09
11.95
8.16
8.28
11.51

Appendix C
Matlab Code

function [min pressure,max pressure,pos int,neg int]=...
Import and Smooth(filename)
%
% Function purpose: To import all the time, pressure, and flowrate data
% from the .csv file as well as to smooth the flowrate data and then
% integrate it in order to determine the total systolic and diastolic flow
% volumes. This function is called in the matlab function Cycle Average.
%
% Syntax:

[min pressure,max pressure,pos int,neg int]=...

% Import and Smooth(filename)
%
% Inputs:
%
%

filename...The name of the file. Created in function Cycle Average.

%
% Outputs:
%
%

min pressure...The peak pressure difference recorded during diastole

%

max pressure...The peak pressure difference recorded during systole
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%

pos int...The portion of the time/flowrate integral that is greater

%

than zero (the systolic flow volume)

%

neg int...The portion of the time/flowrate integral that is less

%

than zero (the diastolic flow volume)

%
% Local Variables:
%

time ms...The array that defines the time imported from the .csv

%

file in milliseconds.

%

time...The array that defines the time imported from the .csv

%

file in seconds.

%

Aortic Pressure...The matrix that holds all the aortic pressure data

%

imported from the .csv file.

%

Ventricular Pressure...The matrix that holds all the ventricular

%

pressure data imported from the .csv file.

%

Flowrate matrix...The matrix that holds all the flowrate data

%

imported from the .csv file.

%

Flowrate vector...The array that holds all the flowrate data

%

imported from the .csv file. It is converted into a vector so that

%

when it is smooted, the tails of the smoothed waveform will have

%

been influenced by data from the beginning or end of other cycles.

%

Flowrate filter vector...The array that houses the filtered flowrate

%

data.

%

Flowrate filter matrix...The matrix that houses the filtered flowrate

%

data. The vector is converted back into a matrix so the data is

%

easier to access.

%

pos q...The matrix that defines where the flowrate is positive

%

neg q...The matrix that defines where the flowrate is negative

%

pos matrix...The matrix that houses the positive values of the

%

flowrate data

%

neg matrix...The matrix that houses the negative values of the

%

flowrate data

%

pos int...The matrix that houses the positive portion of the

%

integral of the time/flowrate data
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%

neg int...The matrix that houses the negative portion of the

%

integral of the time/flowrate data

%

Transaortic Pressure...The matrix that holds the pressure difference

%

between the aortic and ventricular data.

%
% Import time data for first cycle (time interval will be equivelant for...
% all cycles)
time ms = dlmread(filename,',',[19 2 274 2]);
%
% Convert time from milliseconds to seconds
time = zeros(256,1);
for i = 1:256
time(i) = time ms(i)/1000;
end
%
%Import the aortic pressures for all cycles
Aortic Pressure = zeros(256,10);
Aortic Pressure(:,1) = dlmread(filename,',',[19 3 274 3]);
Aortic Pressure(:,2) = dlmread(filename,',',[277 3 532 3]);
Aortic Pressure(:,3) = dlmread(filename,',',[535 3 790 3]);
Aortic Pressure(:,4) = dlmread(filename,',',[793 3 1048 3]);
Aortic Pressure(:,5) = dlmread(filename,',',[1051 3 1306 3]);
Aortic Pressure(:,6) = dlmread(filename,',',[1309 3 1564 3]);
Aortic Pressure(:,7) = dlmread(filename,',',[1567 3 1822 3]);
Aortic Pressure(:,8) = dlmread(filename,',',[1825 3 2080 3]);
Aortic Pressure(:,9) = dlmread(filename,',',[2083 3 2338 3]);
Aortic Pressure(:,10) = dlmread(filename,',',[2341 3 2596 3]);
%
%Import the ventricular pressures for all the cycles
Ventricular Pressure = zeros(256,10);
Ventricular Pressure(:,1) = dlmread(filename,',',[19 4 274 4]);
Ventricular Pressure(:,2) = dlmread(filename,',',[277 4 532 4]);
Ventricular Pressure(:,3) = dlmread(filename,',',[535 4 790 4]);
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Ventricular Pressure(:,4) = dlmread(filename,',',[793 4 1048 4]);
Ventricular Pressure(:,5) = dlmread(filename,',',[1051 4 1306 4]);
Ventricular Pressure(:,6) = dlmread(filename,',',[1309 4 1564 4]);
Ventricular Pressure(:,7) = dlmread(filename,',',[1567 4 1822 4]);
Ventricular Pressure(:,8) = dlmread(filename,',',[1825 4 2080 4]);
Ventricular Pressure(:,9) = dlmread(filename,',',[2083 4 2338 4]);
Ventricular Pressure(:,10) = dlmread(filename,',',[2341 4 2596 4]);
%
% Import the flowrate data for all the cycles into a matrix
Flowrate matrix = zeros(256,10);
Flowrate matrix(:,1) = dlmread(filename,',',[19 7 274 7]);
Flowrate matrix(:,2) = dlmread(filename,',',[277 7 532 7]);
Flowrate matrix(:,3) = dlmread(filename,',',[535 7 790 7]);
Flowrate matrix(:,4) = dlmread(filename,',',[793 7 1048 7]);
Flowrate matrix(:,5) = dlmread(filename,',',[1051 7 1306 7]);
Flowrate matrix(:,6) = dlmread(filename,',',[1309 7 1564 7]);
Flowrate matrix(:,7) = dlmread(filename,',',[1567 7 1822 7]);
Flowrate matrix(:,8) = dlmread(filename,',',[1825 7 2080 7]);
Flowrate matrix(:,9) = dlmread(filename,',',[2083 7 2338 7]);
Flowrate matrix(:,10) = dlmread(filename,',',[2341 7 2596 7]);
%
% Convert flowrate data into vector
Flowrate vector = zeros(1,2560);
for i = 0:9
Flowrate vector(i*256+1:256*(i+1)) = Flowrate matrix...
(i*256+1:256*(i+1));
end
%
% Smooth the flowrate data
g = gausswin(50); % <-- this value determines the width of the
% smoothing window
g = g/sum(g);
Flowrate filter vector = conv(Flowrate vector, g, 'same');
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%
% Convert the filtered flowrate data back into matrix form
Flowrate filter matrix = zeros(256,10);
for i = 0:9
Flowrate filter matrix(i*256+1:256*(i+1)) = Flowrate filter vector...
(i*256+1:256*(i+1));
end
%
% Split the positive and negative flowrate data into separate matrices
pos q = Flowrate filter matrix>0;
neg q = Flowrate filter matrix<0;
pos matrix = pos q. *Flowrate filter matrix;
neg matrix = neg q. *Flowrate filter matrix;
pos int = zeros(10,1);
neg int = zeros(10,1);
for k = 1:10
pos int(k) = trapz(time,pos matrix(:,k));
neg int(k) = trapz(time,neg matrix(:,k));
end
%
% Calculate the Transaortic Pressure for all the cycles
Transaortic Pressure = zeros(256,10);

for i = 1:10
for j = 1:256
Transaortic Pressure(j,i) = Ventricular Pressure(j,i)-...
Aortic Pressure(j,i);
end
end
%
% Calculate max transaortic pressure for each cycle
max pressure = zeros(10,1);
for i = 1:10
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max pressure(i) = max(Transaortic Pressure(:,i));
end
%
% Calculate the min transaortic pressure for each cycle
min pressure = zeros(10,1);
for i = 1:10
min pressure(i) = min(Transaortic Pressure(:,i));
end

function [ave P max,ave P min,ave Qf,ave Qr,SD Qf,SD Qr]=...
Cycle Average(Diameter,Heartrate)
%
% Function purpose: To average all 30 cycles of three separate trials of
% data at 10 different pump flowrates. The average pressure and flowrates
% of those 30 cycles are then plotted, curvefitted, and labeled with an
% error bar.
%
% Syntax:

[ave P max,ave P min,ave Qf,ave Qr,SD Qf,SD Qr]= ...

% Cycle Average(Diameter,Heartrate)
%
% Inputs:
%
%

Diameter...A character string denoting the Shunt Diameter or outer

%

diode diameter as well as whether or not it is a diode or a shunt,

%

what type of test fluid was used, what type of system it was

%

performed in (recirculating or oscillatory) and what data set it

%

is. For example, in the character string 11dgr2:

%

11 - Diameter

%

d

- Diode

%

g

- Glycerin

%

r

- Recirculating System

%

2

- Second set of blood analogue tests performed in the
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%

recirculating system

%

Heartrate...Frequency in bpm

%
% Note that both inputs need to be entered in quotation marks because they
% are character strings. Both of these inputs are used to create the .csv
% file name character string (filename). The file name is then used in the
% Import and Smooth function. Typical file names have four segments used to
% differentiate one from the next. i.e. 11dgr2 195 006 2.csv. The 006
% indicates that this particular .csv file was the 6th set of data taken
% out of 10 different pump flowrates. Because Vivitest captures cycles
% in series of 10, a total of 3 sets of data at each pump flowrate setting
% are required in order to capture 30 cycles. The 2 indicates that this is
% the second set of data at that particular pump flowrate, or cycles
% 11 - 20.
%
% Outputs:
%
%

ave P max...An array listing the average peak systolic pressure of

%

all 30 cycles at each of 10 different pump flowrates.

%

ave P min...An array listing the average peak diastolic pressure of

%

all 30 cycles at each of 10 different pump flowrates.

%

ave Qf...An array listing the average systolic volumetric flows of

%

all 30 cycles at each of 10 different pump flowrates.

%

ave Qr...An array listing the average diastolic volumetric flows of

%

all 30 cycles at each of 10 different pump flowrates.

%

SD Qf...An array listing the standard deviation of the systolic

%

volumetric flows of all 30 cycles at each of 10 different pump

%

flowrates.

%

SD Qr...An array listing the standard deviation of the diastolic

%

volumetric flows of all 30 cycles at each of 10 different pump

%

flowrates

%
% Local Variables:
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%
%

Data Point No...The number of different pump flowrates chosen.

%

Typically ten proved to be sutiable.

%

digits...The number of digits available for use in the

%

identification of the pump flowrate setting

%

P min...The matrix that holds the peak diastolic pressure from

%

each of the 30 cycles.

%

P max...The matrix that holds the peak systolic pressure from

%

each of the 30 cycles.

%

Qr...The matrix that holds the diastolic volumetric flow value from

%

each of the 30 cycles.

%

Qf...The matrix that holds the systolic volumetric flow value from

%

each of the 30 cycles.

%

format...The format of the pump setting segment used in the

%

creation of the file name

%

Trial...The number indicating which set of trials are being

%

evaluated. The numbers range from 1 - 3.

%
% Call out local variables
%
Data Point No = 10;
digits = 3;
P min = zeros(30,10);
P max = zeros(30,10);
Qf = zeros(30,10);
Qr = zeros(30,10);
%
% Create the format for the filename extension for the first 10 different
% pump flowrates
%
format = strcat('%0',num2str(digits),'.0f');
Trial = '1';
%
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% Retrieve the data from the first 10 different pump flowrates using the
% matlab function Import and Smooth
%
for n = 1:Data Point No
file name = strcat(Diameter,' ',Heartrate,' ',num2str(n,format)...
,' ',Trial,'.csv');
[min pressure,max pressure,pos int,neg int]=Import and Smooth...
(file name);
P min(1:10,n) = min pressure;
P max(1:10,n) = max pressure;
Qf(1:10,n) = pos int;
Qr(1:10,n) = neg int;
%
end
%
% Create the format for the filename extension for the second 10 different
% pump flowrates
%
Trial = '2';
%
% Retrieve the data from the second 10 different pump flowrates
%
for n = 1:Data Point No
file name = strcat(Diameter,' ',Heartrate,' ',num2str(n,format),...
' ',Trial,'.csv');
[min pressure,max pressure,pos int,neg int]=Import and Smooth...
(file name);
P min(11:20,n) = min pressure;
P max(11:20,n) = max pressure;
Qf(11:20,n) = pos int;
Qr(11:20,n) = neg int;
end
%
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% Create the format for the filename extension for the third 10 different
% pump flowrates
%
Trial = '3';
%
% Retrieve the data from the third 10 different pump flowrates
for n = 1:Data Point No
file name = strcat(Diameter,' ',Heartrate,' ',num2str(n,format),...
' ',Trial,'.csv');
[min pressure,max pressure,pos int,neg int]=Import and Smooth...
(file name);
P min(21:30,n) = min pressure;
P max(21:30,n) = max pressure;
Qf(21:30,n) = pos int;
Qr(21:30,n) = neg int;
end
%
% Compile all the averages of each set of 30 cycles as well as the
% standard deviations for the forward and reverse flow.
%
ave P max = zeros(10,1);
ave neg P min = zeros(10,1);
ave Qf = zeros(10,1);
ave Qr neg = zeros(10,1);
SD Qf = zeros(10,1);
SD Qr = zeros(10,1);
%
for i = 1:10
ave P max(i) = mean(P max(:,i));
ave neg P min(i) = mean(P min(:,i));
ave Qf(i) = mean(Qf(:,i));
ave Qr neg(i) = mean(Qr(:,i));
SD Qf(i) = std(Qf(:,i));
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SD Qr(i) = std(Qr(:,i));
end
%
% The negative x data cannot be curve fitted using a power function, so
% the pressure data is still represented as positive
%
ave P min = ave neg P min *-1;
%
% The data trends are easier to compare when the curves are in the same
% quadrant
ave Qr = ave Qr neg *-1;
%
% Plot the data points along with an error bar that represents
% plus/minus 1 SD from the given forward flow curvefit
%
errorbar(ave P max,ave Qf,(-SD Qf),(SD Qf),'r*');
xlabel('Peak Systolic Pressure (mmHg)');
ylabel('Total Forward Flow (ml)');
title('Systolic Pressure/Flow Relationship')
legend('Raw Data');
text(4,1.1,'Each error bar represents plus/minus1 standard deviation');
figureHandle = gcf;
%# make all text in the figure to size 14 and bold
set(findall(figureHandle,'type','text'),'fontSize',14)
%
figure
%
% Plot the data points along with an error bar that represents
% plus/minus 1 SD from the given reverse flow curvefit
%
errorbar(ave P min,ave Qr,(-SD Qr),(SD Qr),'r*');
xlabel('Peak Diastolic Pressure (mmHg)');
ylabel('Total Reverse Flow (ml)');
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title('Diastolic Pressure/Flow Relationship')
legend('Raw Data');
text(3,-.4,'Each error bar represents plus/minus1 standard deviation');
figureHandle = gcf;
%# make all text in the figure to size 14 and bold
set(findall(figureHandle,'type','text'),'fontSize',14)
%
% Display the outputs. Curve fits equations can be determined now by
% running the curve fit tool. Command: cftool
%
display(ave P max);
display(ave P min);
display(ave Qf);
display(ave Qr);
display(SD Qf);
display(SD Qr);

